Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Int J Infect Dis
    September 2021
  1. BRUNETTI ND, Poliseno M, Bottalico IF, Centola A, et al
    Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Int J Infect Dis. 2021 Sep 19. pii: S1201-9712(21)00741.
    >> Share

  2. FINSTERER J
    SARS-CoV-2 in cardiomyocytes.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00737.
    >> Share

  3. EGWANG TG, Owalla TJ, Okurut E, Apungia G, et al
    Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00747.
    >> Share

  4. KHALIFA BA, Abbey EJ, Ayeh SK, Yusuf HE, et al
    The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00744.
    >> Share

  5. BONACCORSI G, Paoli S, Biamonte MA, Moscadelli A, et al
    COVID-19 and schools: what is the risk of contagion? The results of an antigen rapid test-based screening campaign in Florence (Italy).
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00734.
    >> Share

  6. CORREIA AM, Borges V, Isidro J, Lima AR, et al
    Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00739.
    >> Share

  7. MORENO A, Vargas C, Azocar F, Villarroel F, et al
    STEROIDS AND MORTALITY IN NON-CRITICALLY ILL COVID-19 PATIENTS: A PROPENSITY SCORE WEIGHTED STUDY IN A CHILEAN COHORT.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00745.
    >> Share

  8. COLANERI M, De Filippo M, Licari A, Marseglia A, et al
    COVID vaccination and asthma exacerbation: might there be a link?
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00733.
    >> Share

  9. DESPHANDE GR, Kaduskar O, Deshpande K, Bhatt V, et al
    Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
    Int J Infect Dis. 2021 Sep 17. pii: S1201-9712(21)00732.
    >> Share

  10. LUTALO T, Nalumansi A, Olara D, Kayiwa J, et al
    Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00728.
    >> Share

  11. VACHARATHIT V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, et al
    SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00729.
    >> Share

  12. BARANDALLA I, Alvarez C, Barreiro P, de Mendoza C, et al
    Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00730.
    >> Share

  13. VON HUTH S, Lillevang ST, Roge BT, Madsen JS, et al
    SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).
    Int J Infect Dis. 2021 Sep 14. pii: S1201-9712(21)00731.
    >> Share

  14. HASAN MR, Kalikiri MKR, Mirza F, Sundararaju S, et al
    Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.
    Int J Infect Dis. 2021 Sep 12. pii: S1201-9712(21)00709.
    >> Share

  15. ZHAO Y, Yang C, An X, Xiong Y, et al
    Follow-up study on the COVID-19 survivors after one year discharged from hospital.
    Int J Infect Dis. 2021 Sep 11. pii: S1201-9712(21)00726.
    >> Share

  16. ELOY P, Tardivon C, Martin-Blondel G, Isnard M, et al
    Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00724.
    >> Share

  17. ZHOU D, Wang Q, Liu H
    Coronavirus disease-19 and the gut-lung axis.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00722.
    >> Share

  18. LEINER J, Pellissier V, Nitsche A, Konig S, et al
    SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00717.
    >> Share

  19. HARA H, Uemura Y, Hayakawa K, Togano T, et al
    Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00725.
    >> Share

  20. LOBIE TA, Roba AA, Booth JA, Kristiansen KI, et al
    Antimicrobial resistance: A challenge awaiting the post COVID-19 era.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00708.
    >> Share

  21. GOLDIN L, Elders T, Werhane L, Korwek K, et al
    Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00713.
    >> Share

  22. BYLICKI O, Delarbre D, Mayet A, Ferrier A, et al
    Neutralizing antibodies response to SARS-CoV-2 are persistent 9 months post symptom onset in mild or asymptomatic patients.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00707.
    >> Share

  23. SATO K, Mano T, Niimi Y, Toda T, et al
    Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
    Int J Infect Dis. 2021 Sep 4. pii: S1201-9712(21)00704.
    >> Share

  24. LOUCA S
    SARS-CoV-2 infections in 165 countries over time.
    Int J Infect Dis. 2021 Sep 3. pii: S1201-9712(21)00701.
    >> Share

  25. VICENTI I, Basso M, Gatti F, Scaggiante R, et al
    Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00683.
    >> Share

  26. NGERE I, Dawa J, Hunsperger E, Otieno N, et al
    sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00696.
    >> Share

    August 2021
  27. DE GUADIANA-ROMUALDO LG, Martinez MM, Mulero MDR, Torrella PE, et al
    Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
    Int J Infect Dis. 2021 Aug 27. pii: S1201-9712(21)00692.
    >> Share

  28. SALVAGNO GL, Henry BM, Lippi G
    The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00693.
    >> Share

  29. DIRKX KKT, Mulder B, Post AS, Rutten MH, et al
    The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00691.
    >> Share

  30. CHEN Y, Yao H, Fu J, Shu Q, et al
    The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00672.
    >> Share

  31. POUR OB, Yahyavi Y, Karimi A, Khamaneh AM, et al
    Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00686.
    >> Share

  32. BHANUPRASAD K, Manesh A, Devasagayam E, Varghese L, et al
    Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic.
    Int J Infect Dis. 2021 Aug 24. pii: S1201-9712(21)00670.
    >> Share

  33. VAN DAM CS, Lede I, Schaar J, Al-Dulaimy M, et al
    Herpes Zoster after COVID-vaccination.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00681.
    >> Share

  34. VAN HEERDEN J, Nel J, Moodley P, Govender P, et al
    Multisystem Inflammatory Syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00673.
    >> Share

  35. YANG J, Han Y, Zhang R, Zhang R, et al
    Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00676.
    >> Share

  36. L SBB, Wanve S, Koradia P, Bhomia V, et al
    Efficacy and Safety of Pegylated Interferon-alpha2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00677.
    >> Share

  37. MOUALLEM RE, Moussally K, Williams A, Repetto E, et al
    How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00668.
    >> Share

  38. TIMELLI L, Liuzzi G, Cannavacciuolo A, Petrosillo N, et al
    Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00665.
    >> Share

  39. GONG C, Song X, Li X, Lu L, et al
    Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00667.
    >> Share

  40. VELAVAN T, Pallerla S, Kremsner P
    How to ab(use) a COVID-19 antigen rapid test with soft drinks?
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00654.
    >> Share

  41. CUI LY, Cheng WW, Mou ZW, Xiao D, et al
    Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00649.
    >> Share

  42. ELMOHEEN A, Abdelhafez I, Awad W, Bahgat M, et al
    External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00660.
    >> Share

  43. PASQUINI Z, Barocci I, Brescini L, Candelaresi B, et al
    Bloodstream infections in the COVID-19 era: results from an Italian multicenter study.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00623.
    >> Share

  44. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    Corrigendum to 'The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20' [International Journal of Infectious Diseases 105 (April 2021) 91-104].
    Int J Infect Dis. 2021;110:337.
    >> Share

  45. TADESSE EB, Endris AA, Solomon H, Alayu M, et al
    Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020.
    Int J Infect Dis. 2021 Aug 16. pii: S1201-9712(21)00661.
    >> Share

  46. IMAI K, Matsuoka M, Tabata S, Kitagawa Y, et al
    Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severity.
    Int J Infect Dis. 2021 Aug 15. pii: S1201-9712(21)00659.
    >> Share

  47. WRIGHT J, Achana F, Diwakar L, Semple MG, et al
    Cycle threshold values are inversely associated with poorer outcomes in hospitalised patients with Covid-19: a prospective, observational cohort study conducted at a UK tertiary hospital.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00657.
    >> Share

  48. SELINGER C, Choisy M, Alizon S
    Predicting COVID-19 incidence in French hospitals using human contact network analytics.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00662.
    >> Share

  49. BIRKHEAD M, Glass AJ, Allan-Gould H, Goossens C, et al
    Ultrastructural evidence for vertical transmission of SARS-CoV2.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00653.
    >> Share

  50. LIANG L, Guo Q, Zhang H, Lin S, et al
    Low infectious risk of re-positive COVID-19 patients: a single-center study.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00652.
    >> Share

  51. KEITOKU K, Nishimura Y, Hagiya H, Koyama T, et al
    Impact of the World Antimicrobial Awareness Week on public interest between 2015 and 2020: A Google Trends analysis.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00651.
    >> Share

  52. MARRA V, Quartin M
    A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00648.
    >> Share

  53. NONAKA CKV, Graf T, Barcia CAL, Costa VF, et al
    SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00635.
    >> Share

  54. SAEED BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, et al
    Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00646.
    >> Share

  55. NAKAMURA Y, Katano H, Nakajima N, Sato Y, et al
    SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00647.
    >> Share

  56. JACOB L, Koyanagi A, Smith L, Haro JM, et al
    Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
    Int J Infect Dis. 2021 Aug 8. pii: S1201-9712(21)00642.
    >> Share

  57. BUTT AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, et al
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00639.
    >> Share

  58. PIMENOFF VN, Bjornstedt M, Dillner J
    Severe features during outbreak but low mortality observed immediately before and after a March-May Covid-19 outbreak in Stockholm, Sweden.: Mortality before, during and after a COVID-19 outbreak.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00637.
    >> Share

  59. DIAZ-AROCUTIPA C, Melgar-Talavera B, Alvarado-Yarasca A, Saravia-Bartra MM, et al
    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00636.
    >> Share

  60. THANGARAJU P, B AK, Venkatesan S
    Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
    Int J Infect Dis. 2021;109:54-55.
    >> Share

    July 2021
  61. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    >> Share

  62. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    >> Share

  63. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    >> Share

  64. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    >> Share

  65. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    >> Share

  66. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    >> Share

  67. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    >> Share

  68. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    >> Share

  69. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    >> Share

  70. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    >> Share

  71. ZANDI M, Behboudi E, Soltani S
    Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some of SARS-CoV-2 proteins?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00611.
    >> Share

  72. PAUL E, Brown GW, Dechamps M, Kalk A, et al
    Covid-19: An extra-terrestrial disease?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00609.
    >> Share

  73. ILIC I, Stojanovic DU, Loncar G
    Influenza immunization and COVID-19 - can viral structure be responsible for the effect?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00610.
    >> Share

  74. AHMED S, Khan WA
    A Five-day Course of Ivermectin may Reduce the Duration of COVID-19 Illness.
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00606.
    >> Share

  75. ALBAHRANI S, AlBarraK A, Alghamdi OA, Abdullah Alghamdi M, et al
    Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Vaccinee in Saudi Arabia.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00608.
    >> Share

  76. BROTONS P, Perez-Arguello A, Launes C, Torrents F, et al
    Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00607.
    >> Share

  77. MARCOLINO MS, Pires MC, Ramos LEF, Silva RT, et al
    ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores.
    Int J Infect Dis. 2021 Jul 23. pii: S1201-9712(21)00605.
    >> Share

  78. GORDON PDMMV, McCarthy PDKA, Proctor PDJL, Hagedorn MBL, et al
    Evaluating COVID-19 reporting data in the context of testing strategies across 31 LMICs.
    Int J Infect Dis. 2021 Jul 22. pii: S1201-9712(21)00599.
    >> Share

  79. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00598.
    >> Share

  80. SIRIPURAPU G, Samad SA, Fatima S, Wig N, et al
    SUCCESSFUL MANAGEMENT OF POST-COVID-19 ACANTHAMOEBIC ENCEPHALITIS.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00602.
    >> Share

  81. GERTLER M, Krause E, van Loon W, Krug N, et al
    Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00601.
    >> Share

  82. LELI C, Matteo LD, Gotta F, Cornaglia E, et al
    Performance of a SARS CoV-2 antigen rapid immunoassay in patients admitted to the Emergency Department.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00597.
    >> Share

  83. OKPALA OV, Dim CC, Ugwu CI, Onyemaechi S, et al
    Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria.
    Int J Infect Dis. 2021 Jul 19. pii: S1201-9712(21)00596.
    >> Share

  84. ALSHUKAIRI AN, El-Kafrawy SA, Dada A, Yasir M, et al
    Re-infection with different SARS-CoV-2 clade and prolonged viral shedding in a patient with hematopoietic stem cell transplantation: SARS-CoV-2 Re-infection with different clade.
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00592.
    >> Share

  85. RENISI G, Lombardi A, Massimo S, Alessandro I, et al
    ANTERIOR UVEITIS ONSET AFTER BNT162b2 VACCINATION: IS THIS JUST A COINCIDENCE?
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00591.
    >> Share

  86. LALWANI P, Salgado BB, Filho IVP, da Silva DSS, et al
    SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00576.
    >> Share

  87. ALKOFIDE H, Almohaizeie A, Almuhaini S, Alotaibi B, et al
    Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00578.
    >> Share

  88. HUSNAYAIN A, Chuang TW, Fuad A, Su EC, et al
    High variability in model performance of Google relative search volume in spatially clustered COVID-19 areas of the United States.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00587.
    >> Share

  89. YAMAGUCHI T, Shinagawa T, Kobata H, Nakagawa H, et al
    Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00571.
    >> Share

  90. MARKEWITZ R, Torge A, Wandinger KP, Pauli D, et al
    Analysis of SARS-CoV-2 RT-qPCR Ct values vis-a-vis anti-SARS-CoV-2 antibodies from a high incidence region.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00570.
    >> Share

  91. DARCIS G, Bouquegneau A, Maes N, Thys M, et al
    Long-term clinical follow up of patients suffering from moderate to severe COVID-19 infection: A monocentric prospective observational cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00572.
    >> Share

  92. TONIASSOA SCC, Fernandesa FS, Jovelevithsb D, Filhoc FFD, et al
    Reduction in COVID-19 prevalence in health care workers in a university hospital in southern Brazil after the start of vaccination.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00582.
    >> Share

  93. CONNOR BA, Couto-Rodriguez M, Barrows JE, Gardner M, et al
    Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00586.
    >> Share

  94. IRWIN N, Murray L, Ozynski B, Richards GA, et al
    nnAge significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00585.
    >> Share

  95. NUNEZ-ZAPATA SF, Benites-Peralta B, Mayta-Tristan P, Rodriguez-Morales AJ, et al
    High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!
    Int J Infect Dis. 2021 Jul 11. pii: S1201-9712(21)00579.
    >> Share

  96. KIM JH, Roh YH, Ahn JG, Kim MY, et al
    Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19.
    Int J Infect Dis. 2021 Jul 7. pii: S1201-9712(21)00560.
    >> Share

  97. MALIK M, Kunze AC, Bahmer T, Herget-Rosenthal S, et al
    SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00567.
    >> Share

  98. SOLDEVILA L, Valerio-Sallent L, Roure S, Perez-Quilez O, et al
    Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00562.
    >> Share

  99. ALSHAMRANI MM, El-Saed A, Zunitan MA, Almulhem R, et al
    Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00564.
    >> Share

  100. ELHARAKE JA, Galal B, Alqahtani SA, Kattan RF, et al
    COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00559.
    >> Share

  101. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00565.
    >> Share

  102. ROVIDA F, Cassaniti I, Percivalle E, Sarasini A, et al
    Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-control study.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00558.
    >> Share

  103. MUCHELENG'ANGA LA, Telendiy V, Hamukale A, Shibemba AL, et al
    COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series.
    Int J Infect Dis. 2021;109:160-167.
    >> Share

  104. JACOB L, Koyanagi A, Smith L, Tanislav C, et al
    Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.
    Int J Infect Dis. 2021 Jul 2. pii: S1201-9712(21)00552.
    >> Share

    June 2021
  105. FERGUSON J, Murugesan K, Banaei N, Liu A, et al
    Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00542.
    >> Share

  106. W T, A A, A T, V V, et al
    Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00545.
    >> Share

  107. BALUSHI AA, AlShekaili J, Kindi MA, Ansari Z, et al
    Immunological predictors of disease severity in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00546.
    >> Share

  108. HSU SH, Chang SH, Gross C, Wang SY, et al
    Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00548.
    >> Share

  109. BUNDGAARD JS, Raaschou-Pedersen DT, Todsen T, Ringgaard A, et al
    Danish Citizen s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00550.
    >> Share

  110. LASTRUCCI V, Bonaccorsi G, Forni S, D'Arienzo S, et al
    The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00547.
    >> Share

  111. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00519.
    >> Share

  112. WIBOWO A, Pranata R, Lim MA, Akbar MR, et al
    Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00540.
    >> Share

  113. KUMAR SHUKLA DA, Misra DS
    Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible.
    Int J Infect Dis. 2021 Jun 24. pii: S1201-9712(21)00535.
    >> Share

  114. SPEECKAERT MM, Delanghe JR
    The potential significance of vitamin D binding protein polymorphism in COVID-19.
    Int J Infect Dis. 2021 Jun 23. pii: S1201-9712(21)00532.
    >> Share

  115. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72].
    Int J Infect Dis. 2021 Jun 22. pii: S1201-9712(21)00498.
    >> Share

  116. BRUNO A, de Mora D, Freire-Paspuel B, Rodriguez AS, et al
    Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.
    Int J Infect Dis. 2021 Jun 21. pii: S1201-9712(21)00526.
    >> Share

  117. KAMALADASA A, Gunasekara B, Jeewandara C, Jayathilaka D, et al
    Comparison of two assays to detect IgG antibodies to the receptor binding domain of the SARSCoV2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
    Int J Infect Dis. 2021 Jun 20. pii: S1201-9712(21)00520.
    >> Share

  118. ALHINAI ZA, Elsidig N
    Countries with similar Covid-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00527.
    >> Share

  119. FW H, Tc L, Dt A, R L, et al
    Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomised controlled trial.
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00523.
    >> Share

  120. TANISALI G, Sozak A, Bulut AS, Sander TZ, et al
    Effectiveness of different types of Masks in Aerosol Dispersion in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00518.
    >> Share

  121. DUARTE CM, Jamil T, Gojobori T, Alam I, et al
    Detection of SARS-CoV-2 variants requires urgent global coordination.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00516.
    >> Share

  122. HIMWAZE CM, Telendiy V, Maate F, Mupeta S, et al
    Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.
    Int J Infect Dis. 2021;108:363-369.
    >> Share

  123. SONG G, Qiao W, Wang X, Yu X, et al
    Association of lung ultrasound score with mortality and severity of COVID-19: A Meta-analysis and Trial Sequential Analysis.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00513.
    >> Share

  124. AKHMETZHANOV AR, Jung SM, Cheng HY, Thompson RN, et al
    A hospital-related outbreak of SARS-CoV-2 associated with a novel variant Cal.20C (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January-February 2021.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00517.
    >> Share

  125. HANS L, Steegen K, Ketseoglou I, Mahlumba Z, et al
    Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00508.
    >> Share

  126. MONEDERO-RECUERO I, Gegia M, Wares DF, S Chadha S, et al
    Situational analysis of the 10 high drug resistant tuberculosis burden countries two years post-UNHLM declaration: progress and setbacks in a changing landscape.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00511.
    >> Share

  127. BOOGAARD LH, Sikkema RS, van Beek J, Brockhoff HJ, et al
    A mixed methods approach to elucidate SARS-CoV-2 transmission routes and clustering in outbreaks in native workers and labour migrants in the fruit and vegetable packaging industry in South Holland, the Netherlands, May to July 2020.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00510.
    >> Share

  128. KASPERSEN KA, Greve T, Nielsen KJ, Jespersen S, et al
    Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00506.
    >> Share

  129. GUZMAN NA, De la Hoz Restrepo F, Serrano-Coll H, Gastelbondo B, et al
    Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00507.
    >> Share

  130. VALLEJO-JANETA AP, Morales-Jadan D, Freire-Paspuel B, Lozada T, et al
    COVID-19 outbreaks at shelters for women victims of gender-based violence from Ecuador.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00501.
    >> Share

  131. MEDINA N, Alastruey-Izquierdo A, Bonilla O, Ortiz B, et al
    Impact of the COVID-19 pandemic on HIV care in Guatemala.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00500.
    >> Share

  132. PORTO MH, Castro B, Diaz Z, Pedroso Y, et al
    SARS-CoV-2 infection in properly vaccinated healthcare workers.
    Int J Infect Dis. 2021 Jun 9. pii: S1201-9712(21)00499.
    >> Share

  133. DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
    SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00493.
    >> Share

  134. CHEN S, Zheng T, Wang S, Yu Y, et al
    Association between risk of VTE and mortality in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00494.
    >> Share

  135. YEN MY, Yen YF, Chen SY, Lee TI, et al
    Learning from the past: Taiwan's responses to COVID-19 versus SARS.
    Int J Infect Dis. 2021 Jun 4. pii: S1201-9712(21)00490.
    >> Share

  136. LI X, Yin Y, Pang L, Xu S, et al
    Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00484.
    >> Share

  137. MAYANSKIY N, Brzhozovskaya E, Fedorova N, Lebedin Y, et al
    Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00486.
    >> Share

  138. KINOSHITA M, Sato K, Vellingiri B, Green SJ, et al
    Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00474.
    >> Share

  139. TOCZYLOWSKI K, Jackowska K, Lewandowski D, Kurylonek S, et al
    Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: severity, seasonal trends, and impact of immunization.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00473.
    >> Share

  140. MOLINA GA, Ayala AV, Endara SA, Aguayo WG, et al
    Ecuador and Covid-19, A Pandemic we won't be able to run away from.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00480.
    >> Share

  141. GREUEL S, Ihlow J, Dragomir MP, Streit S, et al
    COVID-19: Autopsy findings in six patients between 26 and 46 years of age.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00472.
    >> Share

  142. PETERSEN E, Schlagenhauf P, Lee SS, Blumberg L, et al
    Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics.
    Int J Infect Dis. 2021;108:156-158.
    >> Share

  143. RAGHAV K, Anand S, Gothwal A, Singh P, et al
    Underreporting of race/ethnicity in COVID-19 research.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00479.
    >> Share

  144. CAMELENA F, Poncin T, Dudoignon E, Salmona M, et al
    rcent agreement; NPA: negative percent agreeRapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00477.
    >> Share

  145. LEIXNER G, Voill-Glaninger A, Bonner E, Kreil A, et al
    Evaluation of the AMP SARS-CoV-2 Rapid Antigen Test in a Hospital Setting.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00466.
    >> Share

  146. NG DC, Tan KK, Ling C, Ali MM, et al
    Clinical and epidemiological characteristics of children with COVID-19 in Negeri Sembilan, Malaysia.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00476.
    >> Share

  147. KAMSTRUP P, Sivapalan P, Eklof J, Hoyer N, et al
    Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00478.
    >> Share

    May 2021
  148. HIROTSU Y, Sugiura H, Maejima M, Hayakawa M, et al
    Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 May 31. pii: S1201-9712(21)00470.
    >> Share

  149. LIM AY, Cheong HK, Oh YJ, Lee JK, et al
    Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
    Int J Infect Dis. 2021 May 28. pii: S1201-9712(21)00465.
    >> Share

  150. YOUSEFINAGHANI S, Dara R, Mubareka S, Papadopoulos A, et al
    An Analysis of COVID-19 Vaccine Sentiments and Opinions on Twitter.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00462.
    >> Share

  151. PAGNESI M, Inciardi RM, Lombardi CM, Agostoni P, et al
    Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00458.
    >> Share

  152. UMEMURA Y, Mitsuyama Y, Minami K, Nishida T, et al
    Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by Coronavirus disease 2019: An interventional study.
    Int J Infect Dis. 2021 May 25. pii: S1201-9712(21)00456.
    >> Share

  153. ARMINANZAS C, Arnaiz de Las Revillas F, Gutierrez Cuadra M, Arnaiz A, et al
    USEFULNESS OF THE COVID-GRAM AND CURB-65 SCORES FOR PREDICTING SEVERITY IN PATIENTS WITH COVID-19.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00450.
    >> Share

  154. RUBIO CP, Franco-Martinez L, Resalt CS, Torres-Cantero A, et al
    Evaluation of different sample treatments options in a simple and safe procedure for the detection of SARS-COV-2 in saliva.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00455.
    >> Share

  155. LEE H, Noh E, Jeon H, Nam EW, et al
    Association between the traffic level from other areas and the COVID-19 prevalence at the provincial levels in South Korea.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00457.
    >> Share

  156. AHMAD F, Ahmed A, Rajendraprasad SS, Loranger A, et al
    Multisystem Inflammatory Syndrome in Adults: A Rare Sequela of SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00452.
    >> Share

  157. LUKITO AA, Widysanto A, Lemuel TAY, Prasetya IB, et al
    Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study.
    Int J Infect Dis. 2021 May 23. pii: S1201-9712(21)00420.
    >> Share

  158. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Corrigendum to 'Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic.' [Int J Infect Dise. Vol 106 (2021) P323-328].
    Int J Infect Dis. 2021;107:254.
    >> Share

  159. BABU GR, Sundaresan R, Athreya S, Akhtar J, et al
    The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India.
    Int J Infect Dis. 2021 May 21. pii: S1201-9712(21)00445.
    >> Share

  160. CAMICI M, Zuppi P, Lorenzini P, Scarnecchia L, et al
    The role of testosterone in SARS-CoV-2 infection: a key pathogenic factor and a biomarker for severe pneumonia.
    Int J Infect Dis. 2021 May 20. pii: S1201-9712(21)00444.
    >> Share

  161. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00442.
    >> Share

  162. NIELSEN KJ, Vestergaard JM, Schlunssen V, Bonde JP, et al
    Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00434.
    >> Share

  163. KIM J, Gomez REG, Hong K, Yum S, et al
    The changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00441.
    >> Share

  164. RAY JG, Colacci M, Schull MJ, Vermeulen MJ, et al
    Non-ABO red cell antibodies and risk of COVID-19.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00440.
    >> Share

  165. FAY FF, Alvarez-Moreno CA, Bonvehi PE, Espinoza CC, et al
    A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00412.
    >> Share

  166. HAMMER CC, Boender TS, Thomas DR
    Social media for field epidemiologists (#SoMe4epis): How to use Twitter during the #COVID19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00437.
    >> Share

  167. SASIKALA M, Shashidhar J, Deepika G, Ravikanth V, et al
    Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00436.
    >> Share

  168. VICENTI I, Gatti F, Scaggiante R, Boccuto A, et al
    Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00435.
    >> Share

  169. HAYER J, Kasapic D, Zemmrich C
    Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020.
    Int J Infect Dis. 2021 May 17. pii: S1201-9712(21)00431.
    >> Share

  170. ALSHUKAIRI AN, Tolah AM, Dada A, Al-Tawfiq JA, et al
    Test-based De-isolation in COVID-19 Immunocompromised patients: Ct value versus SARS-CoV-2 viral cultures.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00429.
    >> Share

  171. FATTEH N, Sutherland GE, Santos RG, Zeidan R, et al
    Association of Hypothermia with Increased Mortality Rate in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00433.
    >> Share

  172. MUMOLI N, Evangelista I, Colombo A, Conte G, et al
    Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00418.
    >> Share

  173. JASPARD M, Sow MS, Juchet S, Diendere E, et al
    Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00425.
    >> Share

  174. MARTHA JW, Pranata R, Lim MA, Wibowo A, et al
    Active Prescription of Low-dose Aspirin During or Prior to Hospitalization and Mortality in COVID-19 - A Systematic Review and Meta-analysis of Adjusted Effect Estimates.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00417.
    >> Share

  175. ZAQOUT A, Daghfal J, Alaqad I, Hussein SAN, et al
    The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00422.
    >> Share

  176. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Post-vaccination COVID-19 cases among healthcare workers at Siloam Teaching Hospital, Indonesia.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00421.
    >> Share

  177. SMAGHI BS, Collins J, Dagina R, Hiawalyer G, et al
    Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: a multi-methods cross-sectional study, November - December 2020.
    Int J Infect Dis. 2021 May 12. pii: S1201-9712(21)00390.
    >> Share

  178. DE SIQUEIRA IC, Camelier AA, Maciel EAP, Nonaka CKV, et al
    Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00411.
    >> Share

  179. WANNIGAMA DL, Amarasiri M, Hurst C, Phattharapornjaroen P, et al
    Tracking COVID-19 with wastewater to understand asymptomatic transmission.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00406.
    >> Share

  180. WU J, Chen X, Gong L, Huo S, et al
    Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China.
    Int J Infect Dis. 2021 May 10. pii: S1201-9712(21)00376.
    >> Share

  181. ZHANG X, Jiang M, Yang J
    Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19.
    Int J Infect Dis. 2021 May 6. pii: S1201-9712(21)00402.
    >> Share

  182. SUZUKI T, Kutsuna S, Saito S, Kawashima A, et al
    Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00400.
    >> Share

  183. BEZERRA ALVES JG, Natal Figueiroa J, Urquia ML
    Impact of COVID-19 on immunization of Brazilian infants.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00401.
    >> Share

  184. PENA M, Ampuero M, Garces C, Gaggero A, et al
    Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00399.
    >> Share

  185. CAVALCANTE PINTO V JUNIOR, Moura LFWG, Cavalcante RC, Rubens Costa Lima J, et al
    Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00398.
    >> Share

  186. HAUSDORFF WP, Flores J
    Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).
    Int J Infect Dis. 2021;106:78.
    >> Share

  187. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Reply to "Misconceptions and misinformation about bats and viruses".
    Int J Infect Dis. 2021;106:197-198.
    >> Share

    April 2021
  188. NASIRI M, Khodadadi J, Molaei S
    Does vitamin D serum level affect prognosis of COVID-19 patients?
    Int J Infect Dis. 2021 Apr 30. pii: S1201-9712(21)00395.
    >> Share

  189. PETERSEN E, Buchy P
    Vaccination against SARS-CoV-2 should be included in childhood vaccination programs.
    Int J Infect Dis. 2021 Apr 29. pii: S1201-9712(21)00394.
    >> Share

  190. CASTRO ABREU PINTO T, Silva Costa N, Andrade Oliveira LM
    The World Meningitis Day and the WHO roadmap to defeat bacterial meningitis in the COVID-19 pandemic era.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00382.
    >> Share

  191. GERHARDS C, Thiaucourt M, Kittel M, Becker C, et al
    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescent from COVID-19 infection.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00392.
    >> Share

  192. LUO C, Liu M, Li Q, Zheng X, et al
    Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00389.
    >> Share

  193. SONG Y, Chen C, Wang Y, Zhang J, et al
    Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An Observation Cohort Study in China.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00388.
    >> Share

  194. SORIANO V, de Mendoza C, Gomez-Gallego F, Corral O, et al
    Third wave of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00386.
    >> Share

  195. AZNAR ML, Espinosa-Pereiro J, Saborit N, Jove N, et al
    Impact of the COVID-19 pandemic on tuberculosis management in Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00387.
    >> Share

  196. SEVILLANO G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, et al
    Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00385.
    >> Share

  197. AL-MAANI A, Al Wahaibi A, Al-Sooti J, Al Abri B, et al
    The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00383.
    >> Share

  198. BRUZZONE B, De Pace V, Caligiuri P, Ricucci V, et al
    Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00384.
    >> Share

  199. LAGI F, Trevisan S, Piccica M, Graziani L, et al
    Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00377.
    >> Share

  200. LACAP EM JR, Varghese A, Khamis F, Bahrani MA, et al
    Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00381.
    >> Share

  201. D'ABRAMO A, Vita S, Maffongelli G, Mariano A, et al
    Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approach.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00380.
    >> Share

  202. RADULESCU A, Istrate A, Flonta M, Lupse M, et al
    Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00379.
    >> Share

  203. CRUZ C, White NJ
    COVID-19 chemoprevention.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00356.
    >> Share

  204. LEBOURGEOIS S, Storto A, Gout B, Le Hingrat Q, et al
    Performance Evaluation of the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00378.
    >> Share

  205. LEDNICKY JA, Lauzardo M, Alam MM, Elbadry MA, et al
    Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00375.
    >> Share

  206. NEKLUDOVA GV, Avdeev SN, Tsareva NA, Trushenko NV, et al
    Using TAPSE as a predictor of poor prognosis of COVID-19: is it enough?
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00368.
    >> Share

  207. AL-SAKKAF E, Ghaleb Y, Al-Dabis E, Qairan M, et al
    First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities.
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00333.
    >> Share

  208. ARNAUD DE, Apoline SK, Risgou OA, Lucien DD, et al
    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study.
    Int J Infect Dis. 2021 Apr 21. pii: S1201-9712(21)00318.
    >> Share

  209. OSMAN W, Al Fahdi F, Khamis F, Salmi IA, et al
    Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00361.
    >> Share

  210. SUGHAYER MA, Mansour A, Al Nuirat A, Souan L, et al
    Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00371.
    >> Share

  211. BIRLUTIU V, Feiereisz AI, Oprinca G, Dobritoiu S, et al
    Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature.
    Int J Infect Dis. 2021 Apr 19. pii: S1201-9712(21)00370.
    >> Share

  212. SIAMI Z, Aghajanian S, Mansouri S, Mokhames Z, et al
    Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00354.
    >> Share

  213. CAPUTO V, Bax C, Colantoni L, Peconi C, et al
    Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: a study on 4266 samples.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00359.
    >> Share

  214. HANSEN T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, et al
    First case of postmortem study in a patient vaccinated against SARS CoV2.
    Int J Infect Dis. 2021 Apr 16. pii: S1201-9712(21)00364.
    >> Share

  215. KADALI RAK, Janagama R, Peruru S, Malayala SV, et al
    Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Int J Infect Dis. 2021 Apr 15. pii: S1201-9712(21)00358.
    >> Share

  216. AIELLO A, Fard SN, Petruccioli E, Petrone L, et al
    Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00344.
    >> Share

  217. SEET RCS, Quek AML, Ooi DSQ, Sengupta S, et al
    Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00345.
    >> Share

  218. MEHLER K, Jung N, Oberthuer A
    Is it all MIS-C? - Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children (MIS-C) after SARS-CoV2 infection.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00355.
    >> Share

  219. ROEST S, Brugts JJ, van Kampen JJA, von der Thusen JH, et al
    COVID-19-related myocarditis post-heart transplantation.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00324.
    >> Share

  220. GHAFARI M, Kadivar A, Katzourakis A
    Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00326.
    >> Share

  221. INABA M, Higashimoto Y, Toyama Y, Horiguchi T, et al
    Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00329.
    >> Share

  222. HU B, Ning P, Qiu J, Tao V, et al
    Modeling the complete spatiotemporal spread of the COVID-19 epidemic in mainland China.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00332.
    >> Share

  223. METTLER SK, Park J, Ozbek O, Mettler LK, et al
    Diagnostic Serial Interval as an Indicator for Effectiveness of Contact Tracing in the COVID-19 Pandemic - A Simulation Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00340.
    >> Share

  224. OULHAJ A, Alsuwaidi AR, Suliman A, Gasmelseed H, et al
    Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Associate with Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00337.
    >> Share

  225. MAKHOUL K, Shukha Y, Abu Hanna L, Nitecki S, et al
    A Case of Rapidly Progressive Upper Limb Ischemic Necrosis in a Patient with COVID-19.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00334.
    >> Share

  226. MORRIS CR, Iyer S
    Reply to Letter to the Editor regarding hospital-based triage travel screens during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00327.
    >> Share

  227. DEWI R, Kaswandani N, Karyanti MR, Setyant DB, et al
    Mortality in children with COVID-19: Lessons learned from a tertiary referral hospital in Indonesia.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00330.
    >> Share

  228. SCHADE W, Reimer V, Seipenbusch M, Willer U, et al
    Viral aerosol transmission of COVID-19 from simulated human emission in a concert hall.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00339.
    >> Share

  229. WU Q, Hou X, Li H, Guo J, et al
    A Follow-Up Study of Respiratory and Physical Functions After Discharge in re-detectable positive SARS-CoV-2 nucleic acid results in Recovered COVID-19 Patients.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00331.
    >> Share

  230. JAWADE K, Sinha AY, Bhagat S, Bhowmick S, et al
    A novel ORF-1a based SARS-CoV-2 RT-PCR assay to resolve inconclusive samples.
    Int J Infect Dis. 2021 Apr 11. pii: S1201-9712(21)00317.
    >> Share

  231. GABOR JJ, Kreidenweiss A, Weber S, Salama M, et al
    A call to caution when hydroxychloroquine is given to elderly COVID-19 patients.
    Int J Infect Dis. 2021 Apr 10. pii: S1201-9712(21)00320.
    >> Share

  232. SUEN YT, Chan RCH, Wong EMY
    An Exploratory Study of Factors Associated with Difficulties in Accessing HIV Services During COVID-19 among Chinese Gay and Bisexual Men in Hong Kong.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00316.
    >> Share

  233. GOUVEA-REIS FA, Borja LS, Dias PO, Silva DCS, et al
    SARS-CoV-2 among inmates over 60 years of age during a COVID-19 outbreak in a penitentiary complex in Brazil: positive health outcomes despite high prevalence.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00298.
    >> Share

  234. OLLIARO P, Torreele E
    Managing the risks of making the wrong diagnosis: First, do no harm.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00315.
    >> Share

  235. XUE L, Jing S, Sun W, Liu M, et al
    Evaluating the impact of the travel ban within mainland China on the epidemic of the COVID-19.
    Int J Infect Dis. 2021 Apr 7. pii: S1201-9712(21)00306.
    >> Share

  236. FENG YF, Wang KP, Mo JG, Xu YH, et al
    The spatiotemporal trend of renal involvement in COVID-19: a pooled analysis of 17,134 patients.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00300.
    >> Share

  237. JI Y, Shao J, Tao B, Song H, et al
    Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00307.
    >> Share

  238. LAGIER JC, Amrane S, Mailhe M, Gainnier M, et al
    High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00305.
    >> Share

  239. GREENKY D, Linam M, Yaffee A, Costello B, et al
    Response to "Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers (pHCWs)".
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00310.
    >> Share

  240. TRACHOOTHAM D, Thongyen S, Lam-Ubol A, Chotechuang N, et al
    Simultaneously Complete but Not Partial Taste and Smell Losses were Associated with SAR-CoV-2 Infection.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00301.
    >> Share

  241. BAUER G
    Comment to the manuscript by William P. Hausdorff and Jorge Flores: Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19, IJID 103 (2021) 37-41.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00302.
    >> Share

  242. MICHOTTE N, Allard S, Payen MC, Dauby N, et al
    Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome.
    Int J Infect Dis. 2021 Apr 1. pii: S1201-9712(21)00299.
    >> Share

  243. UDWADIA ZF, Barkate H, Patil S, Rangwala S, et al
    Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et a
    Int J Infect Dis. 2021;105:686-687.
    >> Share

  244. AL MOHAJER M, Panthagani KM, Lasco T, Lembcke B, et al
    Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients.
    Int J Infect Dis. 2021;105:252-255.
    >> Share

  245. PUECHMAILLE SJ, Ar Gouilh M, Dechmann D, Fenton B, et al
    Misconceptions and misinformation about bats and viruses.
    Int J Infect Dis. 2021;105:606-607.
    >> Share

  246. ZHOU F, Zhou XH
    Confusion about the definition of imported cases in the early stage of the epidemic.
    Int J Infect Dis. 2021;105:413.
    >> Share

    March 2021
  247. WANG Z, Wang Y, Yang Z, Wu H, et al
    The use of non-invasive ventilation in COVID-19: a systematic review.
    Int J Infect Dis. 2021 Mar 30. pii: S1201-9712(21)00296.
    >> Share

  248. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Hospitalization of mild cases of community-acquired pneumonia decreased more than severe ones during the COVID-19 epidemic.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00292.
    >> Share

  249. NACHEGA JB, Maeurer M, Sam-Agudu NA, Chakaya J, et al
    Bacille Calmette-Guerin (BCG) Vaccine and Potential Cross-Protection against SARS-CoV-2 Infection - Assumptions, Knowns, Unknowns and Need for Developing an Accurate Scientific Evidence Base.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00279.
    >> Share

  250. FOURNIER PE, Colson P, Levasseur A, Devaux CA, et al
    Emergence and outcome of the SARS-CoV-2 "Marseille-4" variant.
    Int J Infect Dis. 2021 Mar 27. pii: S1201-9712(21)00286.
    >> Share

  251. DENNISON D, Khabori MA, Mamari SA, Aurelio A, et al
    Circulating activated neutrophils in COVID-19: an independent predictor for mechanical ventilation and death.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00284.
    >> Share

  252. VELAVAN TP, Meyer CG, Esen M, Kremsner PG, et al
    COVID-19 and Syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00289.
    >> Share

  253. CHEW NWS, Cheong C, Kong G, Phua K, et al
    An Asia-Pacific study on healthcare worker's perception and willingness to receive COVID-19 vaccination.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00287.
    >> Share

  254. KNIPPER M, Sedas AC, Keshavjee S, Abbara A, et al
    The need for protecting and enhancing TB health policies and services for forcibly displaced and migrant populations during the ongoing COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 25. pii: S1201-9712(21)00265.
    >> Share

  255. NYASULU JCY, Munthali RJ, Nyondo-Mipando AL, Pandya H, et al
    COVID-19 pandemic in Malawi: Did public social-political events gatherings contribute to its first wave local transmission?
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00273.
    >> Share

  256. BARRY M, Althabit N, Akkielah L, AlMohaya A, et al
    Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients in a MERS-CoV Referral Hospital during the Peak of the Pandemic.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00276.
    >> Share

  257. MACINTYRE CR, Nguyen PY, Chughtai AA, Trent M, et al
    Mask use, risk mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: a cross-sectional survey.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00274.
    >> Share

  258. NACHEGA JB, Kapata N, Sam-Agudu NA, Decloedt EH, et al
    Minimizing the Impact of the Triple Burden of COVID-19, Tuberculosis and HIV on Health Services in sub-Saharan Africa.
    Int J Infect Dis. 2021 Mar 20. pii: S1201-9712(21)00256.
    >> Share

  259. LISEWSKI AM
    Interim estimates in null models of COVID-19 vaccine effectiveness.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00268.
    >> Share

  260. ZUMLA A, Chakaya J, Khan M, Fatima R, et al
    World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00264.
    >> Share

  261. MBOUMBA BOUASSA RS, Veyer D, Pere H, Belec L, et al
    Analytical performances of the point-of-care SIENNA COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00269.
    >> Share

  262. MURAI Y, Kawasuji H, Takegoshi Y, Kaneda M, et al
    A case of COVID-19 diagnosed with favipiravir induced drug fever based on positive drug-induced lymphocyte stimulation test.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00266.
    >> Share

  263. GABBRIELLI M, Gandolfo C, Anichini G, Candelori T, et al
    How long can SARS-CoV-2 persist in human corpses?
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00270.
    >> Share

  264. EL-SAED A, Alshamrani MM
    RE: COVID-19 and healthcare workers: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00247.
    >> Share

  265. ECOCHARD R, Wimba P, Bengehya J, Bianga PK, et al
    The COVID-19 pandemic is deepening the health crisis in South Kivu.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00261.
    >> Share

  266. FATIMA R, Akhtar N, Yaqoob A, D Harries A, et al
    Building better tuberculosis control systems in a post-COVID world: learning from Pakistan during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00244.
    >> Share

  267. ABRAHA HE, Gessesse Z, Gebrecherkos T, Kebede Y, et al
    Clinical Features and Risk Factors Associated with Morbidity and Mortality Among COVID-19 Patients in Northern Ethiopia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00255.
    >> Share

  268. ALKINDI S, Elsadek RA, Al-Madhani A, Al-Musalhi M, et al
    Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00262.
    >> Share

  269. GHOLAMI M, Khamis AH, Ho SB
    Response to "RE: COVID-19 and healthcare workers: A systematic review and meta-analysis."
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00252.
    >> Share

  270. NISAR MI, Ansari N, Khalid F, Amin M, et al
    Serial population-based sero-surveys for COVID-19 in two neighborhoods of Karachi, Pakistan.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00258.
    >> Share

  271. NOUSHAD M, Al-Saqqaf ISA
    COVID-19: Is herd immunity, the only option for fragile Yemen?
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00248.
    >> Share

  272. ZINELLU A, Paliogiannis P, Carru C, Mangoni AA, et al
    Serum amyloid A concentrations, COVID-19 severity and mortality: an updated systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00243.
    >> Share

  273. NTOUMI F, Mapanguy CCM, Tomazatos A, Pallerla SR, et al
    Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00254.
    >> Share

  274. BASARAN S, Simsek-Yavuz S, Mese S, Cagatay A, et al
    The effect of tocilizumab, anakinra, and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00249.
    >> Share

  275. TANG M, Zhang H, Cai J
    Coronavirus disease 2019 in pregnancy - letter to the editor.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00245.
    >> Share

  276. MORRIS CR, Sullivan P, Mantus G, Sanchez T, et al
    Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00234.
    >> Share

  277. BAVARO DF, Diella L, Fabrizio C, Sulpasso R, et al
    Peculiar clinical presentation of COVID- 19 and predictors of mortality in the elderly: a Multicentre Retrospective Cohort Study.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00239.
    >> Share

  278. SAHU S, Ditiu L, Singh Sachdeva K, Zumla A, et al
    Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00164.
    >> Share

  279. CHAKAYA J, Khan M, Ntoumi F, Aklillu E, et al
    Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00193.
    >> Share

  280. MATHEVET I, Ost K, Traverson L, Zinszer K, et al
    Accounting for health inequities in the design of contact tracing interventions: a rapid review.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00227.
    >> Share

  281. KIZNY GORDON A, Marais B, Walker TM, Sintchenko V, et al
    Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00200.
    >> Share

  282. BAUER G
    The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00072.
    >> Share

  283. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00232.
    >> Share

  284. PETRONE L, Petruccioli E, Vanini V, Cuzzi G, et al
    Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00176.
    >> Share

  285. TIBERI S, Vjecha MJ, Zumla A, Galvin J, et al
    Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00153.
    >> Share

  286. TEN-CATEN F, Gonzalez-Dias P, Castro I, Ogava RLT, et al
    In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00233.
    >> Share

  287. KOCK R, Michel AL, Yeboah-Manu D, Azhar EI, et al
    Zoonotic tuberculosis - The changing landscape.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00177.
    >> Share

  288. NETO FL, Salzstein GA, Cortez AL, Bastos TL, et al
    Comparative Assessment of Mortality Risk Factors Between Admission and Follow-up Models Among Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00230.
    >> Share

  289. ALISHAQ M, Jeremijenko A, Nafady-Hego H, Al Ajmi JA, et al
    SARS-CoV-2 Infection in Mortuary and Cemetery Workers.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00229.
    >> Share

  290. WANG Q, Dong W, Yang K, Ren Z, et al
    Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00231.
    >> Share

  291. KAYA H, Kaji M, Usuda D
    Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00228.
    >> Share

  292. WUNGU CDK, Khaerunnisa S, Putri EAC, Hidayati HB, et al
    Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00225.
    >> Share

  293. SORIANO V, Ganado-Pinilla P, Sanchez-Santos M, Gomez-Gallego F, et al
    Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00201.
    >> Share

  294. CALISTRI P, Amato L, Puglia I, Cito F, et al
    Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00210.
    >> Share

  295. CHAN AX, Ritter M, Bakhoum MF
    Bilateral cotton wool spots after ambulatory COVID-19.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00205.
    >> Share

  296. MONDI A, Lorenzini P, Castilletti C, Gagliardini R, et al
    Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted in an Italian Reference Hospital.
    Int J Infect Dis. 2021 Mar 3. pii: S1201-9712(21)00203.
    >> Share

  297. BERNAS SN, Baldauf H, Wendler S, Heidenreich F, et al
    CCR5Delta32 mutations do not determine COVID-19 disease course.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00195.
    >> Share

  298. WIBOWO A, Pranata R, Akbar MR, Purnomowati A, et al
    The Prognostic Performance of Troponin in COVID-19: A Diagnostic Meta-analysis and Meta-regression.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00199.
    >> Share

  299. LINTON NM, Akhmetzhanov AR, Nishiura H
    Localized end-of-outbreak determination for coronavirus disease 2019 (COVID-19): examples from clusters in Japan.
    Int J Infect Dis. 2021 Mar 1. pii: S1201-9712(21)00192.
    >> Share

    February 2021
  300. BOUDJELAL M, Almajed F, Salman AM, Alharbi NK, et al
    COVID-19 Vaccines: Global Challenges and Prospects Forum Recommendations.
    Int J Infect Dis. 2021 Feb 27. pii: S1201-9712(21)00179.
    >> Share

  301. MEHTA RM, Bansal S, Bysani S, Kalpakam H, et al
    A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00178.
    >> Share

  302. ALMADHI MA, Abdulrahman A, Sharaf SA, AlSaad D, et al
    The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00186.
    >> Share

  303. LOPEZ-MEDRANO F, Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Carretero O, et al
    Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00185.
    >> Share

  304. BYEON KH, Kim DW, Kim J, Choi BY, et al
    Factors Affecting the Survival of Early COVID-19 Patients in South Korea: An Observational Study based on the Korean National Health Insurance Big Data.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00187.
    >> Share

  305. GILI A, Paggi R, Russo C, Cenci E, et al
    Evaluation of automated test Lumipulse(R) G SARS-CoV-2 antigen assay for detection of SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00184.
    >> Share

  306. LU G, Muller O, Li Y
    Imported covid-19 cases: a hot topic with a lack of a clear definition.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00167.
    >> Share

  307. BENNASRALLAH C, Zemni I, Dhouib W, Sriha H, et al
    Factors Associated with a prolonged negative conversion of viral RNA in patients with Coronavirus Disease 2019 (COVID-19).
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00175.
    >> Share

  308. RODRIGUEZ A, Arrizabalaga M, Fernandez-Baca V, Lainez MP, et al
    Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00190.
    >> Share

  309. SINGH V, Upadhyay P, Reddy J, Granger J, et al
    SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00173.
    >> Share

  310. FRANCO-PAREDES C, Suarez JA, Henao-Martinez AF
    Correspondence Global COVID-19 Vaccine Equity Should Precede Requiring Travelers Proof of Vaccination.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00147.
    >> Share

  311. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis".
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00162.
    >> Share

  312. HOANG VT
    Comment to Sands et al: No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00165.
    >> Share

  313. DUGAS M, Grote-Westrick T, Vollenberg R, Lorentzen E, et al
    Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1).
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00171.
    >> Share

  314. VETTER M, Kaufmann MD, Neurath MF, Kremer AE, et al
    Purple Urine in a Patient after Recovery from a SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00169.
    >> Share

  315. MUNOZ M, Patino LH, Ballesteros N, Paniz-Mondolfi A, et al
    Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00159.
    >> Share

  316. NAKAJO K, Nishiura H
    Transmissibility of asymptomatic COVID-19: Data from Japanese clusters.
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00151.
    >> Share

  317. NG JKC, Ngai JCL, Ng SSS, Hui DSC, et al
    Collection of Lower Respiratory Specimen by Bronchoscopy for Diagnosis of COVID-19.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00152.
    >> Share

  318. CYPRIAN F, Sohail MU, Abdelhafez I, Salman S, et al
    SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00156.
    >> Share

  319. SHANKAR H, Champati Ray PK
    GIS-Based Analysis of COVID-19 Cases in India during Pre-lockdown, Lockdown and Unlock Phases.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00157.
    >> Share

  320. BUTTERFIELD TR, Bruce-Mowatt A, Phillips YZR, Brown N, et al
    Assessment of Commercial SARS-CoV-2 Antibody Assays, Jamaica.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00145.
    >> Share

  321. THOMMES L, Burkert FR, Ottl KW, Goldin D, et al
    Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00138.
    >> Share

  322. HUANG E, Isonaka S, Yang H, Salce E, et al
    Tocilizumab Treatment in Critically Ill Patients with COVID-19: A Retrospective Observational Study.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00143.
    >> Share

  323. CHOI YJ, Park MJ, Park SJ, Hong D, et al
    Types of COVID-19 clusters and their relationship with social distancing in Seoul Metropolitan area in South Korea.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00144.
    >> Share

  324. TWOREK A, Jaron K, Uszynska-Kaluza B, Rydzewski A, et al
    Convalescent plasma treatment is associated with lower mortality and better outcomes in high risk COVID-19 patients - propensity score matched case-control study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00140.
    >> Share

  325. MAYNARD S, Ros-Soto J, Chaidos A, Innes A, et al
    The role of ibrutinib in COVID-19 hyperinflammation: a case report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00142.
    >> Share

  326. MUMOLI N, Florian C, Cei M, Evangelista I, et al
    Palliative care in a COVID-19 Internal Medicine Ward: a preliminary report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00139.
    >> Share

  327. DAVIDO B, Gautier S, Riom I, Landowski S, et al
    First wave of COVID-19 in hospital staff members of a tertiary care hospital in the greater Paris area: surveillance and risk factors study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00141.
    >> Share

  328. MEDISETTY MK, Patel A, Pujari S
    Letter to the editor on "Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial" by Udwadia Z et al.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00121.
    >> Share

  329. AL SULAIMAN KA, Al Juhani OA, Eljaaly K, Alharbi AA, et al
    Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multicenter Cohort Study.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00123.
    >> Share

  330. ORTIZ-PRADO E, Rivera-Olivero IA, Freire-Paspuel B, Lowe R, et al
    Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00125.
    >> Share

  331. DE LA CALLE C, Lopez-Medrano F, Pablos JL, Lora-Tamayo J, et al
    Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00127.
    >> Share

  332. STEUWER B, Jamrozik E, Eyal N
    Prioritizing between second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00124.
    >> Share

  333. YANG Q, Xiao X, Gu X, Liang D, et al
    Surveillance of common respiratory infections during COVID-19 pandemic demonstrates preventive effectiveness of non-pharmaceutical interventions.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00113.
    >> Share

  334. ONYEGHALA C, Alasia D, Eyaru O, Nsirim P, et al
    Multisystem Inflammatory Syndrome (MIS-C) in an Adolescent Nigerian Girl with COVID-19: A call for vigilance in Africa.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00103.
    >> Share

  335. MARTHA JW, Pranata R, Wibowo A, Lim MA, et al
    Tricuspid Annular Plane Systolic Excursion (TAPSE) Measured by Echocardiography and Mortality in COVID-19: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00115.
    >> Share

  336. ECHEVERRIA G, Guevara A, Coloma J, Ruiz AM, et al
    Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00120.
    >> Share

  337. MAIA CMF, Marques NP, de Lucena EHG, de Rezende LF, et al
    Increase in the number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00119.
    >> Share

  338. HERRERA LA, Hidalgo-Miranda A, Reynoso-Noveron N, Meneses-Garcia AA, et al
    Saliva is a reliable and accessible source for the detection of SARS-CoV-2.
    Int J Infect Dis. 2021 Feb 10. pii: S1201-9712(21)00095.
    >> Share

  339. YI B, Fen G, Cao D, Cai Y, et al
    Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00106.
    >> Share

  340. BORDONI V, Tartaglia E, Sacchi A, Fimia GM, et al
    The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00105.
    >> Share

  341. KITTEL M, Findeisen P, Muth MC, Thiaucourt M, et al
    Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys(R) Anti-SARS-CoV-2 immunoassay.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00110.
    >> Share

  342. ABDI A, Ahmed AY, Mohamed A, Karanja M, et al
    Preliminary findings of COVID-19 infection in health workers in Somalia: a reason for concern.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00078.
    >> Share

  343. LIMA-MORALES R, Mendez-Hernandez P, Flores YN, Osorno-Romero P, et al
    Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00100.
    >> Share

  344. LY TDA, Nguyen NN, Hoang VT, Goumballa N, et al
    Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00112.
    >> Share

  345. SAIDI O, Malouche D, Saksena P, Arfaoui L, et al
    Impact of contact tracing, respect of isolation and lockdown in reducing the number of cases infected with COVID-19: Case study: Tunisia's response from March 22 to 04 May 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00096.
    >> Share

  346. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    The Effect of Probiotics on Respiratory Tract Infection with Special Emphasis on COVID-19: A Periodic Review during 2010-2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00097.
    >> Share

  347. LIU J, Liu J, He Z, Yang Z, et al
    The duration of SARS-CoV-2 positive in the environments of quarantine rooms: a perspective analysis.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00111.
    >> Share

  348. HIROTSU Y, Maejima M, Shibusawa M, Amemiya K, et al
    Prospective Study of 1,308 Nasopharyngeal Swabs from 1,033 Patients using the LUMIPULSE SARS-CoV-2 Antigen Test: Comparison with RT-qPCR.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00090.
    >> Share

  349. PALKA-KOTLOWSKA M, Custodio-Cabello S, Oliveros-Acebes E, Khosravi-Shahi P, et al
    Review of risk of covid-19 in cancer patients and their cohabitants.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00085.
    >> Share

  350. SEONG H, Hyun HJ, Yun JG, Noh JY, et al
    Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00089.
    >> Share

  351. BISWAS S, Sukla S, Roy S, Nath H, et al
    Response to: Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00074.
    >> Share

  352. ELIAS C, Sekri A, Leblanc P, Cucherat M, et al
    Incubation period of COVID-19: a meta-analysis.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00081.
    >> Share

  353. LAU K, Dorigatti I, Miraldo M, Hauck K, et al
    SARIMA-modelled greater severity and mortality during the 2010/11 post-pandemic influenza season compared to the 2009 H1N1 pandemic in English hospitals.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00082.
    >> Share

  354. SANGINETO M, Arena F, De Nittis R, Villani R, et al
    Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: analysis of 944 patients in Apulia, Italy.
    Int J Infect Dis. 2021 Feb 2. pii: S1201-9712(21)00080.
    >> Share

  355. CAZELLES B, Comiskey C, Nguyen Van Yen B, Champagne C, et al
    Identical trends of SARS-Cov-2 transmission and retail and transit mobility during non-lockdown periods.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00079.
    >> Share

  356. ZHANG J, Xu J, Zhou S, Wang C, et al
    The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00075.
    >> Share

  357. LEE TC, McDonald EG, Butler-Laporte G, Harrison LB, et al
    Remdesivir and Systemic Corticosteroids for the Treatment of COVID-19: A Bayesian Reanalysis.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00077.
    >> Share

    January 2021
  358. OGUZ F, Paseau T, Reper P
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer: if early cytokines scoring results available, to compare with existing severity scores and CT scan observations.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00070.
    >> Share

  359. DIAZ H, Espana G, Castaneda N, Rodriguez L, et al
    Dynamical characteristics of Covid-19 epidemic: Estimation from Colombia's case.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00064.
    >> Share

  360. GUPTA D
    Why are COVID-19 fatality rates among medical doctors higher than those among medical nurses?
    Int J Infect Dis. 2021 Jan 29. pii: S1201-9712(21)00061.
    >> Share

  361. PENARRUBIA L, Ruiz M, Porco R, Rao SN, et al
    In Response to: Multiple assays in a real-time RT-PCR Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00060.
    >> Share

  362. LI H, Xiong N, Li C, Gong Y, et al
    Efficacy of ribavirin and interferon-alpha therapy for hospitalized patients with COVID-19: a multicenter, retrospective cohort study.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00066.
    >> Share

  363. MORETTO F, Sixt T, Devilliers H, Abdallahoui M, et al
    Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19?
    Int J Infect Dis. 2021 Jan 25. pii: S1201-9712(21)00062.
    >> Share

  364. ORONSKY B, Gruber HE, Reiners W, Reid TR, et al
    A Short Discussion About The SARS-CoV-2 mRNA-1273 Vaccine.
    Int J Infect Dis. 2021 Jan 22. pii: S1201-9712(21)00059.
    >> Share

  365. JIAN SW, Kao CT, Chang YC, Chen PF, et al
    Risk Assessment for COVID-19 Pandemic in Taiwan.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00054.
    >> Share

  366. SIDDIQUI SN, Jayasekhar R, Tshering S, Jugjali R, et al
    A Unique Tale of COVID-19 Induced Concomitant Overt DIC and Acute Bi-lateral Pulmonary Embolism.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00051.
    >> Share

  367. LIAO M, Wu J, Dai M, Li H, et al
    Rapid detection of SARS-CoV-2 under replicating or non-replicating status in samples using RT-PCR.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00053.
    >> Share

  368. MOSTAFA A, Kandil S, El-Sayed MH, Girgis S, et al
    SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00048.
    >> Share

  369. SERRE-MIRANDA C, Nobrega C, Roque S, Canto-Gomes J, et al
    Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00049.
    >> Share

  370. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Erratum to "Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia" [Int J Infect Dis 101 (December) (2020) 409-411].
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00034.
    >> Share

  371. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    COVID-19 vaccines under the International Health Regulations - we must use the WHO International Certificate of Vaccination or Prophylaxis.
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00050.
    >> Share

  372. HOONG CWS, Amin MNME, Tan TC, Lee JE, et al
    Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00043.
    >> Share

  373. SCARABEL L, Guardascione M, Dal Bo M, Toffoli G, et al
    Pharmacological strategies to prevent SARS-CoV-2 infection and to treat the early phases of COVID-19 disease.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00046.
    >> Share

  374. AL YAZIDI LS, Al Hinai Z, Al Waili B, Al Hashami H, et al
    Epidemiology, characteristics, and outcomes of hospitalized children with COVID-19 in Oman: A multicenter cohort study.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00047.
    >> Share

  375. BANJAR A, Al-Tawfiq JA, Alruwaily A, Alserehi H, et al
    Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00040.
    >> Share

  376. WILBURN J, Blakey E, Trindall A, Burr H, et al
    COVID-19 within a large prison with high number of vulnerable adults in the UK, March to June 2020: an outbreak investigation and screening event.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00038.
    >> Share

  377. ELEC AD, Oltean M, Goldis P, Cismaru C, et al
    COVID-19 after kidney transplantation: Early outcome and renal function following antiviral treatment.
    Int J Infect Dis. 2021 Jan 13. pii: S1201-9712(21)00033.
    >> Share

  378. DASH P, Turuk J, Behera SK, Palo SK, et al
    Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutated receptor binding domain with ACE2 receptor.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00029.
    >> Share

  379. CHEN M, Qin R, Mei J, Yang Z, et al
    Clinical applications of detecting IgG, IgM, or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00026.
    >> Share

  380. CHEN C, Zhu C, Yan D, Liu H, et al
    The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00027.
    >> Share

  381. GHOLAMI M, Fawad I, Shadan S, Rowaiee R, et al
    COVID-19 and Healthcare Workers: A Systematic Review and Metaanalysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00023.
    >> Share

  382. MARCOLINO MS, Ziegelmann PK, Souza-Silva MVR, do Nascimento IJB, et al
    Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 Registry.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00030.
    >> Share

  383. SHAYAK B, Sharma MM, Gaur M, Mishra AK, et al
    Impact of reproduction number on multiwave spreading dynamics of COVID-19 with temporary immunity: a mathematical model.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00028.
    >> Share

  384. HUANG C, Fei L, Li W, Xu W, et al
    Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00015.
    >> Share

  385. MELIS M, Littera R
    Undetected infectives in the Covid-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00018.
    >> Share

  386. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Low Clinical Performance of "Isopollo COVID19 detection kit" (Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: a call for action against low quality products for developing countries.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00017.
    >> Share

  387. FERNANDEZ-ROJAS MA, Esparza MAL, Romero AC, Calva-Espinosa DY, et al
    Epidemiology of COVID-19 in Mexico, symptomatic profiles and presymptomatic people.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00012.
    >> Share

  388. LUCIEN MAB, Canarie MF, Kilgore PE, Jean-Denis G, et al
    Antibiotics and Antimicrobial Resistance in the COVID-19 Era.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00016.
    >> Share

  389. SOKHNA C, Goumballa N, Hoang VT, Bassene H, et al
    The Grand Magal of Touba was spared by the COVID-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00011.
    >> Share

  390. DA SILVA QUEIROZ JA, de Cassia Pontello Rampazzo R, da Silva Filho EB, Oliveira GS, et al
    Development of a quantitative one-step multiplex RT-qPCR assay for the detection of SARS-CoV-2 in a biological matrix.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00002.
    >> Share

  391. TANDON M, Kataria S, Patel J, Mehta TR, et al
    A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00003.
    >> Share

  392. MARZIALI ME, Hogg RS, Oduwole OA, Card KG, et al
    Predictors of COVID-19 testing rates: A cross-country comparison.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00005.
    >> Share

  393. LUBNOW M, Schmidt B, Fleck M, Salzberger B, et al
    Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression.
    Int J Infect Dis. 2021 Jan 4. pii: S1201-9712(20)32571.
    >> Share

  394. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32603.
    >> Share

  395. IHLOW J, Michaelis E, Greuel S, Heynol V, et al
    B Cell Depletion and Signs of Sepsis Acquired Immunodeficiency in Bone Marrow and Spleen of COVID-19 Deceased.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32602.
    >> Share

  396. KU CW, Durai S, Kwan JQT, Loy SL, et al
    Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32604.
    >> Share

  397. LIU N, Sun J, Wang X, Zhang T, et al
    Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32600.
    >> Share

  398. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46].
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32543.
    >> Share

    December 2020
  399. FOY BH, Wahl B, Mehta K, Shet A, et al
    Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Int J Infect Dis. 2020;103:431-438.
    >> Share

  400. GENERALI D, Bosio G, Malberti F, Cuzzoli A, et al
    Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study.
    Int J Infect Dis. 2020 Dec 29. pii: S1201-9712(20)32597.
    >> Share

  401. LATIANO A, Tavano F, Panza A, Palmieri O, et al
    False Positive Results Of IgM/IgG antibodies against antigen of the SARS-CoV-2 in sera stored before the 2020 Endemia in Italy.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32591.
    >> Share

  402. ROHIT A, Rajasekaran S, Shenoy S, Rai S, et al
    Reprocessing of N95 masks: our experience from a resource limited setting in India.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32594.
    >> Share

  403. LO SH, Lin CY, Hung CT, He JJ, et al
    The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital acquired infections in a Taiwanese hospital.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32596.
    >> Share

  404. IENI A, Tuccari G
    The COVID-19 pandemic: pathologist's support to clinical infectious team.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32593.
    >> Share

  405. BABU GR, Khetrapal S, John DA, Deepa R, et al
    Pandemic Preparedness and Response to COVID-19 in South Asian Countries.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32572.
    >> Share

  406. BATCHI-BOUYOU AL, Lobaloba L, Ndounga M, Vouvoungui JC, et al
    High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32589.
    >> Share

  407. CORTES MF, Espinoza EPS, Noguera SLV, Silva AA, et al
    Decontamination and reuse of surgical masks and respirators during COVID-19 pandemic.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32580.
    >> Share

  408. SANDS K, Wenzel R, McLean L, Korwek K, et al
    No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32583.
    >> Share

  409. WAHAIBI AA, Al-Maani A, Alyaquobi F, Harthy KA, et al
    Effects of COVID-19 on mortality: a 5-year population-based study in Oman.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32578.
    >> Share

  410. LIU Y, Tang JW, Lam TTY
    Transmission dynamics of the COVID-19 epidemics in England.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32579.
    >> Share

  411. CAMPRUBI-FERRER D, Gaya A, Marcos MA, Marti-Soler H, et al
    Persistent replication of SARS-CoV-2 in a severely immunocompromised treated with several courses of remdesivir.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32574.
    >> Share

  412. PAOLUCCI S, Cassaniti I, Novazzi F, Fiorina L, et al
    EBV DNA increase in COVID-19 patients with impaired Lymphocyte subpopulation count.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32575.
    >> Share

  413. RAIMONDI A, Poma G, Piralla A, Meroni V, et al
    Looking for fever in Covid-19 nursing home residents: a false friend?
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32576.
    >> Share

  414. AL-MAHRUQI S, Al-Wahaibi A, Khan AL, Al-Jardani A, et al
    Molecular epidemiology of COVID-19 in Oman: a molecular and surveillance study for the early transmission of COVID-19 in the country.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32573.
    >> Share

  415. JARVA H, Lappalainen M, Luomala O, Jokela P, et al
    Laboratory-based surveillance of COVID-19 in the Greater Helsinki area, Finland, February-June 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32561.
    >> Share

  416. CEVALLOS-VALDIVIEZO H, Vergara-Montesdeoca A, Zambrano-Zambrano G
    Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32567.
    >> Share

  417. WANG Y, Cao Z, Zeng DD, Zhang Q, et al
    The collective wisdom in the COVID-19 research: comparison and synthesis of epidemiological parameter estimates in preprints and peer-reviewed articles.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32563.
    >> Share

  418. HUH K, Ji W, Kang M, Hong J, et al
    Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32565.
    >> Share

  419. CHEN B, Jiang C, Han B, Guan C, et al
    High prevalence of occult thrombosis in mild/moderate COVID-19.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32566.
    >> Share

  420. KOSANOVIC D, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, et al
    Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32568.
    >> Share

  421. HWANG SE, Chang JH, Bumjo O, Heo J, et al
    Possible Aerosol Transmission of COVID-19 Associated with an Outbreak in an Apartment in Seoul, South Korea, 2020.
    Int J Infect Dis. 2020 Dec 17. pii: S1201-9712(20)32558.
    >> Share

  422. LI Y, Shi K, Qi F, Yu Z, et al
    Thalidomide Combined with Short-term Low-Dose Glucocorticoid Therapy for the Treatment of Severe COVID-19: A Case-Series Study.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32546.
    >> Share

  423. FISHER MJ, Raymundo LAM, Monteforte M, Taub EM, et al
    Tocilizumab in the Treatment of Critical COVID-19 Pneumonia: A Retrospective Cohort Study of Mechanically Ventilated Patients.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32544.
    >> Share

  424. FURUSE Y
    Genomic Sequencing Effort for SARS-CoV-2 by Country during the Pandemic.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32557.
    >> Share

  425. LIU J, Li K, Cheng L, Jingjin S, et al
    A high-throughput drug screening strategy against Conroviruses.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32556.
    >> Share

  426. RANDREMANANA R, Lazoumar RH, Tejiokem MC, Manirakiza A, et al
    Institut Pasteur international network's efforts to guide the control measure against Coronavirus Disease 2019 (COVID-19) epidemic among health care workers in Africa.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32553.
    >> Share

  427. CHUN JY, Baek G, Kim Y
    Corrigendum to "Transmission onset distribution of COVID-19" [Int. J. Infect. Dis. 99(October) (2020) 403-407].
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32501.
    >> Share

  428. DELEERS M, Breiman A, Daubie V, Maggetto C, et al
    Covid-19 and blood groups: ABO antibody levels may also matter.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32549.
    >> Share

  429. NI M, Xu H, Luo J, Liu W, et al
    Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32550.
    >> Share

  430. KOWALSKA JD, Kase K, Vassilenko A, Harxhi A, et al
    The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease - a report from Central and Eastern Europe.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32548.
    >> Share

  431. SAXENA S, Khurana A, B S, Sardana K, et al
    Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32547.
    >> Share

  432. RALLI M, Morrone A, Arcangeli A, Ercoli L, et al
    Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters.
    Int J Infect Dis. 2020 Dec 12. pii: S1201-9712(20)32555.
    >> Share

  433. CELOTTO S, Veronese N, Barbagallo M, Ometto F, et al
    An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of hydroxychloroquine and chloroquine therapy.
    Int J Infect Dis. 2020 Dec 11. pii: S1201-9712(20)32541.
    >> Share

  434. BAO Y, Ling Y, Chen YY, Tian D, et al
    Dynamic Anti-Spike Protein Antibody Profiles in COVID-19 Patients.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32537.
    >> Share

  435. HU P, Ma M, Jing Q, Ma Y, et al
    Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32534.
    >> Share

  436. OLIYNYK OV, Rorat M, Barg W
    Oxygen metabolism markers as predictors of mortality in severe COVID-19.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32535.
    >> Share

  437. NILSSON AC, Holm DK, Justesen US, Gorm-Jensen T, et al
    Comparison of six commercially available SARS-CoV-2 antibody assays - choice of assay depends on intended use.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32540.
    >> Share

  438. LINSCHOTEN M, Nab L, van der Horst ICC, Tieleman R, et al
    Response to "Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32529.
    >> Share

  439. KITTEL M, Muth M, Zahn I, Roth P, et al
    Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32526.
    >> Share

  440. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32531.
    >> Share

  441. VERHEIJEN S, van Luin M, Bruggemann RJ, de Mast Q, et al
    More gastro-intestinal adverse events in non-ICU hospitalized COVID-19 patients treated with chloroquine versus hydroxychloroquine.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32533.
    >> Share

  442. SIKKENS JJ, Collard D, Peters EJG
    Comparison of hospital treatment strategy or of actually received treatment with hydroxychloroquine in COVID-19?
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32530.
    >> Share

  443. TARTERET P, Strazzulla A, Rouyer M, Gore C, et al
    Clinical features and medical care factors associated with mortality in French nursing homes during COVID-19 outbreak.
    Int J Infect Dis. 2020 Dec 7. pii: S1201-9712(20)32527.
    >> Share

  444. JARYNOWSKI A, Wojta-Kempa M
    Exploring the link between risk perception in Internet media and COVID-19 prevalence in Europe.
    Int J Infect Dis. 2020 Dec 5. pii: S1201-9712(20)32525.
    >> Share

  445. ALSHARIDAH S, Ayed M, Ameen RM, Alhuraish F, et al
    COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
    Int J Infect Dis. 2020 Dec 4. pii: S1201-9712(20)32513.
    >> Share

  446. GUPTA M, Mohanta SS, Rao A, Parameswaran GG, et al
    Transmission dynamics of the COVID-19 epidemic in India and modelling optimal lockdown exit strategies.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32522.
    >> Share

  447. LUDWIG M, Jacob J, Basedow F, Andersohn F, et al
    Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32520.
    >> Share

  448. AHMED S, Karim MM, Ross AG, Hossain MS, et al
    A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32506.
    >> Share

  449. TORRES B, Alcubilla P, Gonzalez-Cordon A, Inciarte A, et al
    Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32523.
    >> Share

  450. ZHANG M, Du L, Faleti OD, Huang J, et al
    Higher pharyngeal epithelial gene expression of Angiotensin-Converting Enzyme-2 in upper respiratory infection patients.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32512.
    >> Share

  451. MILLER FD, La Croix S, Brown T, Ramsey LT, et al
    Unique pattern of COVID-19 infection in the State of Hawai'i.
    Int J Infect Dis. 2020 Dec 1. pii: S1201-9712(20)32517.
    >> Share

  452. MALAGON-ROJAS J, Parra E, Mercado M
    Letter to the editor on "Asymptomatic infection by SARS 2 coronavirus: Invisible but invincible" by Nikolai et al. 2020.
    Int J Infect Dis. 2020;101:391-392.
    >> Share

  453. LANGER-GOULD A
    Editorial Response to Drs. Simone and Mancusi.
    Int J Infect Dis. 2020;101:367.
    >> Share

    November 2020
  454. VELAVAN TP, Meyer CG
    COVID-19: A PCR-defined pandemic.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32504.
    >> Share

  455. VITA S, Di Bari V, Corpolongo A, Goletti D, et al
    Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32503.
    >> Share

  456. MOTAYO BO, Oluwasemowo OO, Olusola BA, Akinduti PA, et al
    Evolution and genetic diversity of SARSCoV-2 in Africa using whole genome sequences.
    Int J Infect Dis. 2020 Nov 28. pii: S1201-9712(20)32505.
    >> Share

  457. SAHA J, Chouhan P
    Lockdown and unlock for COVID-19 and its impact on residential mobility in India: an analysis of the COVID-19 Community Mobility Reports, 2020.
    Int J Infect Dis. 2020 Nov 27. pii: S1201-9712(20)32502.
    >> Share

  458. NAGY B, Fejes Z, Szentkereszty Z, Suto R, et al
    A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32497.
    >> Share

  459. RASAMBAINARIVO F, Rasoanomenjanahary A, Rabarison JH, Ramiadantsoa T, et al
    Monitoring for outbreak associated excess mortality in an African city: Detection limits in Antananarivo, Madagascar.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32495.
    >> Share

  460. SOVANN L, Sar B, Kab V, Yann S, et al
    An influenza A(H3N2) virus outbreak during the COVID-19 pandemic, Kingdom of Cambodia, 2020.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32491.
    >> Share

  461. HERTZOG RG, Bicheru NS, Popescu DM, Calborean O, et al
    Hypoxic preconditioning - a non-pharmacological approach in COVID-19 prevention.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32494.
    >> Share

  462. JANAPALA RN, Patel J, Belfaqeeh O, Alhashmi A, et al
    Novaferon, Treatment in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32493.
    >> Share

  463. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    Reply to "Novaferon, Treatment in COVID-19 Patients".
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32492.
    >> Share

  464. CASSAR MR, Borg D, Camilleri L, Schembri A, et al
    A novel use of telemedicine during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Nov 24. pii: S1201-9712(20)32481.
    >> Share

  465. FERREIRA CE, Bonvehi PE, de la Torre JCG, Saenz-Flor KV, et al
    Algorithms for testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A consensus statement from a panel of Latin American experts.
    Int J Infect Dis. 2020 Nov 21. pii: S1201-9712(20)32484.
    >> Share

  466. TSANKOV BK, Allaire JM, Irvine MA, Lopez AA, et al
    Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32475.
    >> Share

  467. FINDEISEN P, Stiegler H, Lopez-Calle E, Schneider T, et al
    Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32474.
    >> Share

  468. HABICHT ME, Eppenberger PE, Ruhli F
    A critical assessment on proposed outbreaks of plague and other epidemic diseases in Ancient Egypt.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32470.
    >> Share

  469. MILETO D, Foschi A, Mancon A, Merli S, et al
    A case of extremely prolonged viral shedding: could cell cultures be a diagnostic tool to drive the COVID-19 patients discharge?
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32472.
    >> Share

  470. HAUSDORFF WP, Flores J
    Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32482.
    >> Share

  471. VAN NGUYEN Q, Cao DA, Nghiem SH
    The Spread of COVID-19 and Policy Responses in Vietnam: An Overview.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32466.
    >> Share

  472. ILIC I, Zdravkovic M, Timcic S, Stojanovic DU, et al
    Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32465.
    >> Share

  473. NGIAM JN, Chew N, Tham SM, Beh DL, et al
    Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young, migrant workers with reduced risk of severe disease.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32467.
    >> Share

  474. ALCOBA-FLOREZ J, Gil-Campesino H, Garcia-Martinez de Artola D, Diez-Gil O, et al
    Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32468.
    >> Share

  475. BALKHAIR A, Al-Zakwani I, Al Busaidi M, Al-Khirbash A, et al
    Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32458.
    >> Share

  476. FEDERGRUEN A, Naha S
    Crowding Effects Dominate Demographic Attributes in COVID-19 Cases.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32267.
    >> Share

  477. RABERAHONA M, Rakotomalala R, Rakotomijoro E, Rahaingoalidera T, et al
    Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32462.
    >> Share

  478. DAIA C, Scheau C, Neagu G, Andone I, et al
    Nerve conduction study and electromyography findings in patients recovering from Covid-19 - case report.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32455.
    >> Share

  479. PATRIQUIN G, LeBlanc JJ
    SARS-CoV-2 sensitivity limbo - how low can we go?
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32446.
    >> Share

  480. GORNY AW, Bagdasarian N, Koh Hong Kiat A, Lim YC, et al
    SARS-CoV-2 in Migrant Worker Dormitories: Geospatial Epidemiology Supporting Outbreak Management.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32457.
    >> Share

  481. UDWADIA ZF, Singh P, Barkate H, Patil S, et al
    Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32453.
    >> Share

  482. TIWARI A, So MKP, Chong ACY, Chan JNL, et al
    Pandemic Risk of COVID-19 Outbreak in the United States: An Analysis of Network Connectedness with Air Travel Data.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32454.
    >> Share

  483. KUMAR G, Adams A, Hererra M, Rojas ER, et al
    Predictors and Outcomes of HAIs in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 15. pii: S1201-9712(20)32447.
    >> Share

  484. ZOU H, Lu J, Liu J, Wong JH, et al
    Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
    Int J Infect Dis. 2020 Nov 14. pii: S1201-9712(20)32460.
    >> Share

  485. GIANDHARI J, Pillay S, Wilkinson E, Tegally H, et al
    Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32322.
    >> Share

  486. LI P, Wang Y, Peppelenbosch MP, Ma Z, et al
    Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32321.
    >> Share

  487. PATTERSON BK, Seethamraju H, Dhody K, Corley MJ, et al
    CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14.
    Int J Infect Dis. 2020 Nov 10. pii: S1201-9712(20)32305.
    >> Share

  488. RODRIGUEZ-NAVA G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, et al
    Performance of the Quick COVID-19 Severity Index and the Brescia-COVID Respiratory Severity Scale in hospitalized patients with COVID-19 in a community hospital setting.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32314.
    >> Share

  489. XIAO J, Hu J, He G, Liu T, et al
    The time-varying transmission dynamics of COVID-19 and synchronous actions in China.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32316.
    >> Share

  490. JAIN A, Rophina M, Mahajan S, Krishnan BB, et al
    Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32290.
    >> Share

  491. KHAMIS F, Al Naabi H, Al Lawati A, Ambusaidi Z, et al
    Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32319.
    >> Share

  492. TSO FY, Lidenge SJ, Pena PB, Clegg AA, et al
    High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
    Int J Infect Dis. 2020 Nov 8. pii: S1201-9712(20)32310.
    >> Share

  493. JANG S, Rhee JY, Wi YM, Jung BK, et al
    Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32302.
    >> Share

  494. GRIMES JM, Khan S, Badeaux M, Rao RM, et al
    Arginine Depletion as a Therapeutic Approach for Patients with COVID-19.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32304.
    >> Share

  495. SHI F, Wei Y, Xia L, Shan F, et al
    Lung volume reduction and infection localization revealed in big data CT imaging of COVID-19.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32300.
    >> Share

  496. VIMERCATI L, De Maria L, Quarato M, Caputi A, et al
    COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32298.
    >> Share

  497. LOPEZ JH, Romo AS, Molina DC, Hernandez GA, et al
    DETECTION OF SARS-CoV-2 IN AIR OF TWO HOSPITAL IN HERMOSILLO, SONORA, MEXICO, UTILIZING A LOW-COST ENVIRONMENTAL MONITORING SYSTEM.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32293.
    >> Share

  498. TAKAHASHI W, Yoneda T, Koba H, Ueda T, et al
    Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32297.
    >> Share

  499. AL-QAHTANI M, AlAli S, Abdul Rahman AK, Salman Alsayyad A, et al
    The prevalence of asymptomatic and symptomatic COVID19 disease in a cohort of quarantined subjects.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32294.
    >> Share

  500. JAISWAL V, Nasa P, Raouf M, Gupta M, et al
    Therapeutic Plasma Exchange followed by Convalescent Plasma transfusion in critical COVID-19- an exploratory study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32289.
    >> Share

  501. IPPOLITO G, Lauria FN, Locatelli F, Magrini N, et al
    Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.
    Int J Infect Dis. 2020 Nov 2. pii: S1201-9712(20)32303.
    >> Share

  502. VEEPANATTU P, Singh S, Mendelson M, Nampoothiri V, et al
    Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Int J Infect Dis. 2020;100:278-282.
    >> Share

    October 2020
  503. TEHRANI S, Killander A, Astrand P, Jakobsson J, et al
    Risk factors for mortality in adult COVID-19 patients; frailty predicts fatal outcome in older patients.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32276.
    >> Share

  504. FU H, Wang H, Xi X, Boonyasiri A, et al
    A database for the epidemic trends and control measures during the first wave of COVID-19 in mainland China.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32279.
    >> Share

  505. ERDEM H, Lucey DR
    Health Care Worker Infections and Deaths due to COVID-9: A Survey from 37 Nations and a Call for WHO to Post National Data on their Website.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32268.
    >> Share

  506. JOSHI S, Parkar J, Ansari A, Vora A, et al
    Role of favipiravir in the treatment of COVID-19.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32273.
    >> Share

  507. PIRALLA A, Ricchi M, Cusi MG, Prati P, et al
    Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19: is prolonged quarantine always justified?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32278.
    >> Share

  508. JAEGER LH, Nascimento TC, Rocha FD, Vilela FMP, et al
    Adjusting RT-qPCR conditions to avoid unspecific amplification in SARS-CoV-2 diagnostic.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32283.
    >> Share

  509. BROUQUI P, Amrane S, Million M, Cortaredona S, et al
    Asymptomatic hypoxia in COVID-19 is associated with poor outcome.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32271.
    >> Share

  510. OLIVIERI A, Palu G, Sebastiani G
    Covid-19 cumulative incidence, intensive care and mortality in Italian regions compared to selected European countries.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32277.
    >> Share

  511. NALUMANSI A, Lutalo T, Kayiwa J, Watera C, et al
    Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32275.
    >> Share

  512. DANIELE F, Albert F
    The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32274.
    >> Share

  513. EBRAHIM SH, Gozzer E, Ahmed Y, Imtiaz R, et al
    COVID19 in the Least Developed Fragile and Conflict-Affected Countries - How Can the Most Vulnerable be Protected?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32259.
    >> Share

  514. CELIK HG, Keske S, Sener U, Tekbas M, et al
    Why we should be more careful using hydroxychloroquine in influenza season?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32284.
    >> Share

  515. XIAO D, Li X, Su X, Mu D, et al
    Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32263.
    >> Share

  516. BO Y, Guo C, Lin C, Zeng Y, et al
    Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32270.
    >> Share

  517. PASSARELLI VC, Faico-Filho K, Moreira LVL, Cunha AP, et al
    Asymptomatic COVID-19 in hospital visitors: underestimated potential of viral shedding.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32261.
    >> Share

  518. RAOULT D
    How useful is serology for COVID-19?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32262.
    >> Share

  519. CHOI MJ, Kang M, Shin SY, Noh JY, et al
    Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32266.
    >> Share

  520. YASSINE HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, et al
    Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32246.
    >> Share

  521. ESPINDOLA OM, Brandao CO, Gomes YCP, Siqueira M, et al
    Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32247.
    >> Share

  522. HIRAYAMA A, Masui J, Murayama A, Fujita S, et al
    The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32255.
    >> Share

  523. LOEVINSOHN G, Hardick J, Sinywimaanzi P, Fenstermacher KZJ, et al
    Respiratory pathogen diversity and co-infections in rural Zambia.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32258.
    >> Share

  524. CABELLO A, Zamarro B, Nistal S, Victor V, et al
    COVID-19 DISEASE IN PEOPLE LIVING WITH HIV: A MULTICENTER CASE-SERIES STUDY.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32264.
    >> Share

  525. GODIN A, Xia Y, Buckeridge DL, Mishra S, et al
    The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling study of surveillance data.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32251.
    >> Share

  526. HERNANDEZ-MORA MG, Cabello Ubeda A, Perez LP, Alvarez FV, et al
    Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32249.
    >> Share

  527. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2 and RP targets for SARS-CoV-2 diagnosis.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32250.
    >> Share

  528. MASYENI S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, et al
    Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32248.
    >> Share

  529. BURREL S, Hausfater P, Dres M, Pourcher V, et al
    Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32244.
    >> Share

  530. CHEN CWS, Lee S, Dong MC, Taniguchi M, et al
    What Factors Drive the Satisfaction of Citizens on Governments' Responses to COVID-19?
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32254.
    >> Share

  531. SHAROV KS
    HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32253.
    >> Share

  532. VELAVAN TP, Meyer CG
    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
    Int J Infect Dis. 2020 Oct 17. pii: S1201-9712(20)32238.
    >> Share

  533. VENUGOPAL U, Jilani N, Rabah S, Shariff MA, et al
    SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32240.
    >> Share

  534. HERZBERG J, Vollmer T, Fischer B, Becher H, et al
    A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32230.
    >> Share

  535. LAWAL Y
    Africa's low COVID-19 mortality rate: A paradox?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32242.
    >> Share

  536. ABAYOMI A, Odukoya O, Osibogun A, Wright O, et al
    Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32228.
    >> Share

  537. NAKAMOTO T, Ishikane M, Sasaki R, Ohmagari N, et al
    Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32233.
    >> Share

  538. MOHAMMAD A, Alshawaf E, Marafie SK, Abu-Farha M, et al
    Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32237.
    >> Share

  539. BAECK M, Herman A
    COVID toes: where do we stand with the current evidence?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32225.
    >> Share

  540. DAUBY N, Bottieau E
    The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32236.
    >> Share

  541. STAADEGAARD L, Taylor RJ, Spreeuwenberg P, Caini S, et al
    Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32241.
    >> Share

  542. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32231.
    >> Share

  543. MOHANA A, Sulaiman T, Mahmoud N, Hassanein M, et al
    Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32235.
    >> Share

  544. MADSEN LW, Lindvig SO, Rasmussen LD, Knudtzen FC, et al
    Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
    Int J Infect Dis. 2020 Oct 12. pii: S1201-9712(20)32221.
    >> Share

  545. LAI CC, Wang JH, Hsueh PR
    Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32214.
    >> Share

  546. ZHOU F, You C, Zhang X, Qian K, et al
    Epidemiological Characteristics and Factors Associated with Critical Time Intervals of COVID-19 in Eighteen Provinces, China: A Retrospective Study.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32220.
    >> Share

  547. PIETSCH H, Escher F, Aleshcheva G, Baumeier C, et al
    Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32215.
    >> Share

  548. KIMURA T, Namkoong H
    Susceptibility of obese population to COVID-19.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32218.
    >> Share

  549. KLAUSNER Z, Fattal E, Hirsch E, Shapira SC, et al
    A single holiday was the turning point of the COVID-19 policy of Israel.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32219.
    >> Share

  550. ZHANG K, Vilches TN, Tariq M, Galvani AP, et al
    The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32204.
    >> Share

  551. COTA G, Freire ML, de Souza CS, Pedras MJ, et al
    Diagnostic performance of commercially available COVID-19 serology tests in Brazil.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32211.
    >> Share

  552. NAGANT C, Ponthieux F, Smet J, Dauby N, et al
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32206.
    >> Share

  553. AL MASKARI Z, Al Blushi A, Khamis F, Al Tai A, et al
    Characteristic of Healthcare Workers Infected with COVID-19, a Cross-Sectional Observational Study.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32212.
    >> Share

  554. GAUTRET P, Colson P, Lagier JC, Camoin-Jau L, et al
    Different pattern of the second outbreak of COVID-19 in Marseille, France.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32208.
    >> Share

  555. SHIM E, Tariq A, Chowell G
    Spatial variability in reproduction number and doubling time across two waves of the COVID-19 pandemic in South Korea, February to July 2020.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32210.
    >> Share

  556. SIMULUNDU E, Mupeta F, Chanda-Kapata P, Saasa N, et al
    First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32196.
    >> Share

  557. JIAN SW, Cheng HY, Huang XT, Liu DP, et al
    Contact tracing with digital assistance in Taiwan's COVID-19 outbreak response.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32200.
    >> Share

  558. RUBIO-RIVAS M, Ronda M, Padulles A, Mitjavila F, et al
    Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32202.
    >> Share

  559. SHIRIN T, Bhuiyan TR, Charles RC, Amin S, et al
    Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
    Int J Infect Dis. 2020 Oct 5. pii: S1201-9712(20)32199.
    >> Share

  560. SUN M, Ruan X, Li Y, Wang P, et al
    Clinical characteristics of 30 COVID-19 patients with epilepsy: a retrospective study in Wuhan.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32191.
    >> Share

  561. CALDERARO A, De Conto F, Buttrini M, Piccolo G, et al
    Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32189.
    >> Share

  562. DE SIMONE G, Mancusi C
    Finding the right time for anti-inflammatory therapy in COVID-19.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32170.
    >> Share

  563. NEWALL AT, Leong RNF, Nazareno A, Muscatello DJ, et al
    Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: evolution in the estimated risk of mortality throughout the epidemic.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32194.
    >> Share

  564. TAO J, Gao H, Zhu S, Yang L, et al
    Influenza versus COVID-19 cases among influenza-illness-like patients in travelers from Wuhan to Hong Kong in January 2020.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32190.
    >> Share

  565. MALVIYA A
    The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Int J Infect Dis. 2020;99:310-311.
    >> Share

    September 2020
  566. LUCA P, Cassandro C, Ralli M, Gioacchini FM, et al
    Sudden sensorineural hearing loss and COVID-19: (commentary about "Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss" from Osman Kilic,
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32183.
    >> Share

  567. MUSA HH, Musa TH, Musa IH, Musa IH, et al
    Addressing Africa's pandemic puzzle: perspectives on COVID-19 infection and mortality in sub-Saharan Africa.
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32172.
    >> Share

  568. BAGHAKI S, Yalcin CE, Baghaki HS, Aydin SY, et al
    COX2 Inhibition in the Treatment of COVID-19: Review of Literature to Propose Celecoxib Repositioning for Randomized Controlled Studies.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32182.
    >> Share

  569. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32175.
    >> Share

  570. MAZHAR F, Hadi MA, Kow CS, Marran AMN, et al
    Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32186.
    >> Share

  571. MEYEROWITZ-KATZ G, Merone L
    A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32180.
    >> Share

  572. KALCIOGLU MT, Cag Y, Kilic O, Tuysuz O, et al
    May COVID-19 cause sudden sensorineural hearing loss?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32184.
    >> Share

  573. VASSALLO M, Manni S, Pini P, Blanchouin E, et al
    Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32154.
    >> Share

  574. BLAGOJEVIC NR, Bosnjakovic D, Vukomanovic V, Arsenovic S, et al
    Acute pericarditis and SARS-CoV-2: case report.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32156.
    >> Share

  575. FACCINI-MARTINEZ AA, Rivero R, Garay E, Garcia A, et al
    Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32167.
    >> Share

  576. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Reply to "SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?"
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32178.
    >> Share

  577. KAMINSKI MA, Sunny S, Balabayova K, Kaur A, et al
    Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32164.
    >> Share

  578. FINSTERER J, Scorza FA
    SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32177.
    >> Share

  579. SHAO S, Wang Y, Kang H, Tong Z, et al
    Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32159.
    >> Share

  580. AGERGAARD CN, Lis-Tonder J, Olsen DA, Kierkegaard H, et al
    Challenging diagnostics in familial transmission from asymptomatic COVID-19 carrier. Should we group SARS-CoV-2 samples from households?
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32158.
    >> Share

  581. TAKOI H, Togashi Y, Fujimori D, Kaizuka H, et al
    Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32166.
    >> Share

  582. KARAHASAN YAGCI A, Can Sarinoglu R, Bilgin H, Yanilmaz O, et al
    Relationship of the Cycle Threshold Values of SARS-CoV-2 Polymerase Chain Reaction and Total Severity Score of Computerized Tomography in Patients with COVID 19.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32165.
    >> Share

  583. CHAABNA K, Doraiswamy S, Mamtani R, Cheema S, et al
    Facemask use in community settings to prevent respiratory infection transmission: a rapid review and meta-analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32150.
    >> Share

  584. ISERNIA V, Julia Z, Le Gac S, Bachelard A, et al
    SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32152.
    >> Share

  585. KHABA MC, Ngale TC, Madala N
    COVID-19 in an HIV-infected patient. Lessons learned from an autopsy case.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32151.
    >> Share

  586. SKRIP L, Derra K, Kabore M, Noori N, et al
    Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32148.
    >> Share

  587. ABDULRAHMAN A, AlAli S, Yaghi O, Shabaan M, et al
    COVID-19 and Sickle Cell Disease in Bahrain.
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32149.
    >> Share

  588. WANNIGAMA DL, Jacquet A
    NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS- CoV2?
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32145.
    >> Share

  589. MUKWENHA S, Dzinamarira T, Mugurungi O, Musuka G, et al
    Maintaining robust HIV and TB services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Int J Infect Dis. 2020 Sep 23. pii: S1201-9712(20)32141.
    >> Share

  590. COLSON P, Esteves-Vieira V, Giraud-Gatineau A, Zandotti C, et al
    Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France.
    Int J Infect Dis. 2020 Sep 22. pii: S1201-9712(20)32133.
    >> Share

  591. PINNETTI C, Vergori A, Agrati C, Castilletti C, et al
    SARS-CoV-2 infection does not induce HIV viral escape in Central Nervous System: a case series.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30756.
    >> Share

  592. MORENO-PEREZ O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, et al
    Hypokalemia as a sensitive biomarker of disease severity and invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30749.
    >> Share

  593. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Tomasoni D, et al
    The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.
    Int J Infect Dis. 2020;100:67-74.
    >> Share

  594. SELTZER S
    Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30757.
    >> Share

  595. LV H, Zhang W, Zhu Z, Xiong Q, et al
    Prevalence and recovery time of olfactory and gustatory dysfunctions of hospitalized patients with COVID19 in Wuhan, China.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30755.
    >> Share

  596. BABIN S
    Use of Weather Variables in SARS-CoV-2 Transmission Studies.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30748.
    >> Share

  597. PICON RV, Carreno I, da Silva AA, Mossmann M, et al
    Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30745.
    >> Share

  598. ALAJMI J, Jeremijenko AM, Abraham JC, Alishaq M, et al
    COVID-19 Infection Among Healthcare Workers in a National Healthcare System: the Qatar Experience.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30743.
    >> Share

  599. OWOLABI OA, Jallow AO, Jallow M, Sowe G, et al
    Delay in diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30744.
    >> Share

  600. LETELLIER A, Gibelin A, Voiriot G, Fartoukh M, et al
    Destructive pulmonary fibrosis after severe COVID-19 pneumonia.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30741.
    >> Share

  601. LEDNICKY JA, Lauzardo M, Hugh Fan Z, Jutla A, et al
    Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30739.
    >> Share

  602. NG MY, Wan EYF, Wong HYF, Leung ST, et al
    Development and Validation of Risk Prediction Models for COVID-19 Positivity in a Hospital Setting.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30738.
    >> Share

  603. ZHANG A, Leng Y, Zhang Y, Wu K, et al
    Meta-Analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30737.
    >> Share

  604. ZHAO SZ, Wong JYH, Luk TT, Wai AKC, et al
    Mental health crisis under COVID-19 pandemic in Hong Kong, China.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30746.
    >> Share

  605. VALENZUELA-RODRIGUEZ G, Zambrano LI, Munoz-Lara F, Pecho-Silva S, et al
    Intranational differences in the case fatality rates for COVID-19 among Peruvian physicians.
    Int J Infect Dis. 2020 Sep 13. pii: S1201-9712(20)30735.
    >> Share

  606. AFRIN LB, Weinstock LB, Molderings GJ
    Covid-19 Hyperinflammation and Post-Covid-19 Illness May Be Rooted in Mast Cell Activation Syndrome.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30732.
    >> Share

  607. JOTHIMANI D, Kailasam E, Danielraj S, Nallathambi B, et al
    COVID-19: Poor outcomes in patients with Zinc deficiency.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30730.
    >> Share

  608. WEN J, Cheng Y, Ling R, Dai Y, et al
    Antibody-dependent enhancement of Coronavirus.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30731.
    >> Share

  609. SUARDI LR, Pallotto C, Esperti S, Tazzioli E, et al
    Risk factors for non-invasive/invasive-ventilatory support in patients with COVID-19 pneumonia: a retrospective study within a multidisciplinary approach.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30728.
    >> Share

  610. EGHTESSADI R, Mukandavire Z, Mutenherwa F, Cuadros D, et al
    Safeguarding gains in the Sexual and Reproductive Health and AIDS Response amidst COVID-19: The Role of African Civil Society.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30725.
    >> Share

  611. AZIZ AB, Raqib R, Khan WA, Rahman M, et al
    Integrated control of COVID-19 in resource poor countries.
    Int J Infect Dis. 2020 Sep 8. pii: S1201-9712(20)30724.
    >> Share

  612. YASUI Y, Yasui H, Suzuki K, Saitou T, et al
    Analysis of the predictive factors for critical illness of COVID-19 during treatment - Relationship between serum zinc level and critical illness of COVID-19.
    Int J Infect Dis. 2020 Sep 7. pii: S1201-9712(20)30723.
    >> Share

  613. DUGAS M, Schrempf IM, Ochs K, Frommel C, et al
    Association of contact to small children with mild course of COVID-19.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30720.
    >> Share

  614. SILVERIO A, Di Maio M, Ciccarelli M, Carrizzo A, et al
    Timing of national lockdown and mortality in COVID-19: the Italian experience.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30722.
    >> Share

  615. STEIN RA, Young LM
    From ACE2 to COVID-19: A Multiorgan Endothelial Disease.
    Int J Infect Dis. 2020 Sep 4. pii: S1201-9712(20)30716.
    >> Share

  616. NIKOLAI LA, Meyer CG, Kremsner PG, Velavan TP, et al
    Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30706.
    >> Share

  617. OZOG DM, Sexton JZ, Narla S, Pretto-Kernahan CD, et al
    The Effect of Ultraviolet C Radiation Against Different N95 Respirators Inoculated with SARS-CoV-2.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30709.
    >> Share

  618. ABUHABIB AA, Abu-Aita SN, Procter C, Al-Smeri I, et al
    Unique situation of Gaza Strip dealing with COVID-19 crisis.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30699.
    >> Share

  619. TRAN TA, Cezar R, Frandon J, Kabani S, et al
    CT scan does not make a diagnosis of Covid-19: a cautionary case report.
    Int J Infect Dis. 2020 Sep 2. pii: S1201-9712(20)30703.
    >> Share

  620. BELDOMENICO PM
    Response to Gal Almogy: Superspreaders do matter.
    Int J Infect Dis. 2020;98:187.
    >> Share

    August 2020
  621. CORCHUELO J, Ulloa FC
    Oral manifestations in a patient with a history of asymptomatic COVID-19. Case Report.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30700.
    >> Share

  622. ABOU GHAYDA R, Lee KH, Han YJ, Ryu S, et al
    Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30694.
    >> Share

  623. BAI Y, Jiang D, Lon JR, Chen X, et al
    Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30695.
    >> Share

  624. SCIALPI M
    Pneumonia misinterpretation in COVID-19: revisitation and update.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30696.
    >> Share

  625. REGEN F, Eren N, Heuser I, Hellmann-Regen J, et al
    A Simple Approach to Optimum Pool Size for Pooled SARS-CoV-2 Testing.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30692.
    >> Share

  626. MAHER B, Chavez R, Tomaz GCQ, Nguyen T, et al
    A fluid mechanics explanation of the effectiveness of common materials for respiratory masks.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30621.
    >> Share

  627. KIM YJ, Seo MH, Yeom HE
    Discussion on selecting the number of breaks in the pattern of spread of COVID-19 (a reply to Zhao and Liang).
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30693.
    >> Share

  628. ZHAO S, Liang X
    A re-analysis to identify the structural breaks in the COVID-19 transmissibility during the early phase of the outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30690.
    >> Share

  629. COLEBUNDERS R, Siewe Fodjo JN, Vanham G, Van den Bergh R, et al
    A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30687.
    >> Share

  630. SADASIVAM B, Atal S, Ray A, Sharma S, et al
    The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30688.
    >> Share

  631. TORRES JP, Izquierdo G, Acuna M, Pavez D, et al
    Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30691.
    >> Share

  632. HINOJOSA-VELASCO A, de Oca PVB, Garcia-Sosa LE, Mendoza-Duran JG, et al
    A Case Report of Newborn Infant with Severe COVID-19 in Mexico: Detection of SARS-CoV-2 in Human Breast Milk and Stool.
    Int J Infect Dis. 2020 Aug 26. pii: S1201-9712(20)30684.
    >> Share

  633. GUAN Q, Sadykov M, Mfarrej S, Hala S, et al
    A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30681.
    >> Share

  634. MARVISI M, Ferrozzi F, Balzarini L, Mancini C, et al
    First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30683.
    >> Share

  635. ADAMSON PC, Goodman-Meza D, Vijayan T, Yang S, et al
    Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles.
    Int J Infect Dis. 2020 Aug 21. pii: S1201-9712(20)30678.
    >> Share

  636. XU Y, Cheng M, Chen X, Zhu J, et al
    Current approach in laboratory testing for SARS-CoV-2.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30671.
    >> Share

  637. AL WAHAIBI A, Al Manji A, Al Maani A, Al Rawahi B, et al
    COVID-19 epidemic monitoring after non-pharmaceutical interventions: the use of time-varying reproduction number in a country with a large migrant population.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30668.
    >> Share

  638. LIU J, Zeng W, Cao Y, Cui Y, et al
    Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30674.
    >> Share

  639. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Bats in Ecosystems and their Wide Spectrum of Viral Infectious Threats: SARS-CoV-2 and other emerging viruses.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30680.
    >> Share

  640. MACAULEY P, Martin A, Epelbaum O
    CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30670.
    >> Share

  641. TAKAHASHI H, Iwasaki Y, Watanabe T, Ichinose N, et al
    Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30677.
    >> Share

  642. AHERFI S, Gautret P, Chaudet H, Raoult D, et al
    Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30679.
    >> Share

  643. PETERSEN E, Zumla A
    Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing.
    Int J Infect Dis. 2020 Aug 18. pii: S1201-9712(20)30675.
    >> Share

  644. GENDROT M, Duflot I, Boxberger M, Delandre O, et al
    Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
    Int J Infect Dis. 2020 Aug 14. pii: S1201-9712(20)30661.
    >> Share

  645. LU YF, Pan LY, Zhang WW, Cheng F, et al
    A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Aug 13. pii: S1201-9712(20)30652.
    >> Share

  646. OBOH MA, Omoleke SA, Ajibola O, Manneh J, et al
    Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30656.
    >> Share

  647. KOH WC, Naing L, Wong J
    Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30655.
    >> Share

  648. ORTOLAN A, Lorenzin M, Felicetti M, Doria A, et al
    Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30607.
    >> Share

  649. LIM JT, Dickens BL, Cook AR, Khoo AL, et al
    The Costs of an Expanded Screening Criteria for COVID-19: A Modelling Study.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30654.
    >> Share

  650. HIROTSU Y, Maejima M, Shibusawa M, Nagakubo Y, et al
    Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30658.
    >> Share

  651. KLOPFENSTEIN T, Zayet S, Lohse A, Selles P, et al
    Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30653.
    >> Share

  652. IM JH, Je YS, Baek J, Chung MH, et al
    Nutritional status of patients with coronavirus disease 2019 (COVID-19).
    Int J Infect Dis. 2020 Aug 11. pii: S1201-9712(20)30647.
    >> Share

  653. ISRAELI O, Beth-Din A, Paran N, Stein D, et al
    Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30644.
    >> Share

  654. LA HOZ-RESTREPO F, Alvis-Zakzuk NJ, la Hoz-Gomez JF, la Hoz-Gomez A, et al
    Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data. March to July 2020.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30646.
    >> Share

  655. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244].
    Int J Infect Dis. 2020;98:440.
    >> Share

  656. DEL BRUTTO OH, Costa AF, Mera RM, Recalde BY, et al
    SARS-CoV-2-related mortality in a rural Latin American population.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30630.
    >> Share

  657. ANDERSON M, Mossialos E
    Time to strengthen capacity in infectious disease control at the European level.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30631.
    >> Share

  658. ZUMLA A, Azhar EI, Shafi S, Memish ZA, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 7. pii: S1201-9712(20)30643.
    >> Share

  659. GUPTA R, Gant VA, Williams B, Enver T, et al
    Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30632.
    >> Share

  660. MUMOLI N, Vitale J, Mazzone A
    Clinical Immunity in Discharged Medical Patients with COVID 19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30623.
    >> Share

  661. LIN YC, Chen MY, Liu MC, Lin YJ, et al
    Quarantine Measures for Coronavirus Disease 2019 on a Cruise Ship, Taiwan, February 2020.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30641.
    >> Share

  662. GAO J, Hu X, Sun X, Luo X, et al
    Possible intrauterine infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30608.
    >> Share

  663. MARTINCIC Z, Skopec B, Rener K, Mavric M, et al
    Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30633.
    >> Share

  664. KLOPFENSTEIN T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, et al
    New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30637.
    >> Share

  665. METTLER SK, Kim J, Maathuis MH
    Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30611.
    >> Share

  666. CHUN JY, Baek G, Kim Y
    Transmission onset distribution of COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30612.
    >> Share

  667. JUNG CY, Park H, Kim DW, Choi YJ, et al
    Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30634.
    >> Share

  668. ZUMLA A, Azhar EI, Alqahtani S, Shafi S, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30635.
    >> Share

  669. VARISCO TJ, Johnson ML, Thornton D
    Comment on Arshad et al: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30617.
    >> Share

  670. LIU T, Gong D, Xiao J, Hu J, et al
    Cluster infections play important roles in the rapid evolution of COVID-19 transmission: a systematic review.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30619.
    >> Share

  671. POTERE N, Di Nisio M, Rizzo G, La Vella M, et al
    Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30616.
    >> Share

  672. BHAT P, Noval M, Doub JB, Heil E, et al
    COVID-19 and PCP co-infection in a severely immunocompromised 25 year-old patient.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30615.
    >> Share

  673. WU J, Yu J, Zhou S, Zhang J, et al
    What can we learn from a COVID-19 lung biopsy?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30610.
    >> Share

  674. BRITO-AZEVEDO A
    Hydroxychloroquine in COVID-19: taking care of statistic to take care of patients.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30614.
    >> Share

  675. GODDEK S
    Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30624.
    >> Share

  676. CAPONE A
    Simultaneous circulation of COVID-19 and flu in Italy: potential combined effects on the risk of death?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30618.
    >> Share

  677. PRASETYO YT, Castillo AM, Salonga LJ, Sia JA, et al
    Factors Affecting Perceived Effectiveness of COVID-19 Prevention Measures among Filipino during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and Extended Theory of Planned Behavior.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30622.
    >> Share

  678. WISEMAN DM
    Re: Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis: 2020. Epub 2020 Jul 1 http://doi.org/10.1016/j.ijid.2020.06.099.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30613.
    >> Share

  679. LANGER-GOULD A, Smith JB, Gonzales EG, Castillo RD, et al
    Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30609.
    >> Share

  680. VERHAGEN LM, de Groot R, Lawrence CA, Taljaard J, et al
    COVID-19 response in low- and middle-income countries: don't overlook the role of mobile phone communication.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30625.
    >> Share

  681. UHM JS, Ahn JY, Hyun JH, Sohn Y, et al
    Patterns of Viral Clearance in the Natural Course of Asymptomatic Coronavirus Disease 2019 (COVID-19): Comparison with Symptomatic Nonsevere COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30620.
    >> Share

  682. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Critical illness myopathy after COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30606.
    >> Share

  683. ZHAO D, Wang M, Wang M, Zhao Y, et al
    Asymptomatic infection by SARS-CoV-2 in healthcare workers: a study in a large teaching hospital in Wuhan, China.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30627.
    >> Share

  684. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30597.
    >> Share

  685. ZHANG W, Li L, Liu J, Chen L, et al
    The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30514.
    >> Share

  686. LU J, Wu D, Cao L, Ma X, et al
    Corrigendum to "Positive effects of COVID-19 control measures on pneumonia prevention" [Int J Infect Dis 96 (July) (2020) 548-549].
    Int J Infect Dis. 2020;97:404.
    >> Share

    July 2020
  687. ZERVOS M, Arshad S, Kilgore P, Chaudhry ZS, et al
    A Sound Approach: Hydroxychloroquine Reduces Mortality in Severe COVID-19.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30604.
    >> Share

  688. IWATA K, Doi A, Miyakoshi C
    Was school closure effective in mitigating coronavirus disease 2019 (COVID-19)? Time series analysis using Bayesian inference.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30598.
    >> Share

  689. ALCOBA-FLOREZ J, Gil-Campesino H, de Artola DG, Gonzalez-Montelongo R, et al
    Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30603.
    >> Share

  690. ATKINSON JG
    Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin and Combination in Patients Hospitalized with COVID-19".
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30602.
    >> Share

  691. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Marchetti G, et al
    Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30600.
    >> Share

  692. ROSENBERG ES, Holtgrave DR, Udo T
    Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30599.
    >> Share

  693. TAN L, Ma B, Lai X, Han L, et al
    Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China.
    Int J Infect Dis. 2020 Jul 27. pii: S1201-9712(20)30571.
    >> Share

  694. KESKE S, Tekin S, Sait B, Irkoren P, et al
    Appropriate use of Tocilizumab in COVID-19 Infection.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30580.
    >> Share

  695. NAKAGAWARA K, Masaki K, Uwamino Y, Kabata H, et al
    Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30578.
    >> Share

  696. KANEKURA T, Kawahara K
    Adsorptive granulocyte and monocyte apheresis: a potentially relevant therapeutic option for COVID-19.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30569.
    >> Share

  697. ZHOU Y, Yang Q, Chi J, Dong B, et al
    Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30572.
    >> Share

  698. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during COVID-19 outbreak.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30566.
    >> Share

  699. SINHA P, Mostaghim A, Bielick CG, McLaughlin A, et al
    Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30568.
    >> Share

  700. ABENZA-ABILDUA MJ, Novo-Aparicio S, Moreno-Zabaleta R, Algarra-Lucas MC, et al
    Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
    Int J Infect Dis. 2020;98:398-400.
    >> Share

  701. LUETHGEN M, Eggeling J, Heyckendorf J, Lange C, et al
    Changes in taste and smell as an early marker for COVID-19.
    Int J Infect Dis. 2020 Jul 21. pii: S1201-9712(20)30562.
    >> Share

  702. LEE JY, Hong SW, Hyun M, Park JS, et al
    Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.
    Int J Infect Dis. 2020 Jul 20. pii: S1201-9712(20)30561.
    >> Share

  703. DE SOUSA E, Ligeiro D, Lerias JR, Zhang C, et al
    Mortality in COVID-19 disease patients: Correlating Association of Major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
    Int J Infect Dis. 2020 Jul 18. pii: S1201-9712(20)30560.
    >> Share

  704. FUGLEBJERG NJU, Jensen TO, Hoyer N, Ryrso CK, et al
    Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.
    Int J Infect Dis. 2020 Jul 11. pii: S1201-9712(20)30557.
    >> Share

  705. SUN M, Xu Y, He H, Zhang L, et al
    Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30542.
    >> Share

  706. SAIDAN MN, Shbool MA, Arabeyyat OS, T Al-Shihabi S, et al
    Estimation of the probable outbreak size of novel coronavirus (COVID-19) in social gathering events and industrial activities.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30540.
    >> Share

  707. DIOSCORIDI L, Carrisi C
    Covid-19 exposure risk for family members of healthcare workers: an observational study.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30541.
    >> Share

  708. DENG Z, Zhang M, Zhu T, Liu Z, et al
    Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30545.
    >> Share

  709. KIM S, Castro MC
    Spatiotemporal pattern of COVID-19 and government response in South Korea (as of May 31, 2020).
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30546.
    >> Share

  710. ALMOGY G
    Superspreaders and the spread pattern of COVID-19: Response to: "Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19", International Journal of Infectious Diseases 96 (2020) 461-463.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30537.
    >> Share

  711. AL-SADEQ DW, Nasrallah GK
    The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30533.
    >> Share

  712. ARSHAD S, Kilgore P, Chaudhry ZS, Jacobsen G, et al
    Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30534.
    >> Share

  713. YU X, Duan J, Jiang Y, Zhang H, et al
    Distinctive trajectories of COVID-19 epidemic by age and gender: a retrospective modeling of the epidemic in South Korea.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30536.
    >> Share

  714. LEE TC, MacKenzie LJ, McDonald EG, Tong SYC, et al
    An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30530.
    >> Share

  715. TANG B, Xia F, Tang S, Bragazzi NL, et al
    The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemic in the final phase of the current outbreak in China.
    Int J Infect Dis. 2020;96:636-647.
    >> Share

  716. ZHANG H, Li HB, Lyu JR, Lei XM, et al
    Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.
    Int J Infect Dis. 2020;96:19-24.
    >> Share

  717. ZHU W, Li X, Wu Y, Xu C, et al
    Community quarantine strategy against coronavirus disease 2019 in Anhui: An evaluation based on trauma center patients.
    Int J Infect Dis. 2020;96:417-421.
    >> Share

    June 2020
  718. DE NARDO P, Gentilotti E, Mazzaferri F, Cremonini E, et al
    Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30516.
    >> Share

  719. DUBERT M, Visseaux B, Isernia V, Bouadma L, et al
    Case reports study of the first five patients COVID-19 treated with remdesivir in France.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30528.
    >> Share

  720. ALKHAMIS MA, Youha SA, Khajah MM, Haider NB, et al
    Spatiotemporal Dynamics of COVID-19 epidemic in the State of Kuwait.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30512.
    >> Share

  721. CHEN X, Zhu B, Hong W, Zeng J, et al
    Associations of Clinical Characteristics and Treatment Regimens with Viral RNA Shedding Duration in Patients with COVID-19.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30526.
    >> Share

  722. NOH JY, Song JY, Yoon JG, Seong H, et al
    Safe Hospital Preparedness in the Era of COVID-19: The Swiss Cheese Model.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30529.
    >> Share

  723. SEIDU AA, Hagan JE Jr, Ameyaw EK, Ahinkorah BO, et al
    The role of testing in infectious disease control: A case of COVID-19 in Africa.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30525.
    >> Share

  724. LIANG Y, Xu J, Chu M, Mai J, et al
    Neurosensory dysfunction: a diagnostic marker of early COVID-19.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30519.
    >> Share

  725. BAJUNIRWE F, Izudi J, Asiimwe S
    Long distance truck drivers and the increasing risk of COVID-19 spread in Uganda.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30522.
    >> Share

  726. SHEN C, Yue X, Wang J, Shi C, et al
    Nocturnal oxygen therapy as an option for early COVID-19.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30515.
    >> Share

  727. MANNUCCI E, Nreu B, Monami M
    Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30510.
    >> Share

  728. FUKUMOTO T, Iwasaki S, Fujisawa S, Hayasaka K, et al
    Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30509.
    >> Share

  729. HE D, Shi Z, Li Y, Cao P, et al
    Comparing COVID-19 and the 1918-19 influenza pandemics in United Kingdom.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30511.
    >> Share

  730. AHMED MAM, Colebunders R, Siewe Fodjo JN
    Evidence for important COVID-19 community transmission in Somalia using a clinical case definition.
    Int J Infect Dis. 2020 Jun 25. pii: S1201-9712(20)30503.
    >> Share

  731. ADAMU AA, Jalo RI, Habonimana D, Wiysonge CS, et al
    COVID-19 and routine childhood immunization in Africa: leveraging systems thinking and implementation science to improve immunization system performance.
    Int J Infect Dis. 2020 Jun 24. pii: S1201-9712(20)30507.
    >> Share

  732. BAVARO DF, Poliseno M, Scardapane A, Belati A, et al
    Occurrence of Acute Pulmonary Embolism in COVID-19 - A Case Series.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30501.
    >> Share

  733. VELAVAN TP, Pollard AJ, Kremsner PG
    Herd Immunity and Vaccination of children for COVID19.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30500.
    >> Share

  734. KHAMIS F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, et al
    Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30499.
    >> Share

  735. GALVIN CJ, Li Jack YC, Malwade S, Syed-Abdul S, et al
    COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30496.
    >> Share

  736. AMZAT J, Aminu K, Kolo VI, Akinyele AA, et al
    Coronavirus Outbreak in Nigeria: Burden and Socio-Medical Response during the First 100 Days.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30502.
    >> Share

  737. TARIQ A, Mateen RM, Afzal MS, Saleem M, et al
    Paromomycin: a potential dual targeted drug effectively inhibits both Spike (S1) and Main Protease of COVID-19.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30498.
    >> Share

  738. LAM HY, Lam TS, Wong CH, Lam WH, et al
    The Epidemiology of COVID-19 cases and the Successful Containment Strategy in Hong Kong - January to May 2020.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30492.
    >> Share

  739. HE S, Zhou C, Lu D, Yang H, et al
    Relationship between Chest CT manifestations and immune response in COVID-19 patients.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30494.
    >> Share

  740. POURGHASEMI HR, Pouyan S, Heidari B, Farajzadeh Z, et al
    Spatial modelling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between 19 February to 14 June 2020).
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30493.
    >> Share

  741. SARTOR G, Riccio MD, Poz ID, Bonanni P, et al
    COVID-19 in Italy: considerations on official data.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30495.
    >> Share

  742. AMIR M, Djaharuddin I, Sudharsono A, Ramadany S, et al
    COVID-19 Concomitant Infective Endocarditis: A-Case Report and Review of Management.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30497.
    >> Share

  743. KIM YJ, Seo MH, Yeom HE
    Estimating a breakpoint in the spread pattern of COVID-19 in South Korea.
    Int J Infect Dis. 2020 Jun 19. pii: S1201-9712(20)30489.
    >> Share

  744. ALESSANDRA D, Lepore L, Palazzolo C, Barreca F, et al
    Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30491.
    >> Share

  745. EBRAHIM SH, Zhuo J, Gozzer E, Ahmed QA, et al
    All Hands on Deck: A Synchronized Whole-of-World Approach for COVID-19 Mitigation.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30484.
    >> Share

  746. KRONBICHLER A, Kresse D, Yoon S, Lee KH, et al
    Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jun 17. pii: S1201-9712(20)30487.
    >> Share

  747. LOBO AP, Cardoso-Dos-Santos AC, Rocha MS, Pinheiro RS, et al
    COVID-19 epidemic in Brazil: where we at?
    Int J Infect Dis. 2020 Jun 16. pii: S1201-9712(20)30479.
    >> Share

  748. TURCATO G, Panebianco L, Zaboli A, Scheurer C, et al
    Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department.
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30468.
    >> Share

  749. FILICE C, Poma GL, Above E, Dellafiore C, et al
    Is the fear of Covid-19 infection the same in all subjects?
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30475.
    >> Share

  750. GUALLAR MP, Meirino R, Donat-Vargas C, Corral O, et al
    Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30470.
    >> Share

  751. EBINA-SHIBUYA R, Namkoong H, Shibuya Y, Horita N, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30450.
    >> Share

  752. SATICI C, Demirkol MA, Altunok ES, Gursoy B, et al
    Performance of Pneumonia Severity Index and CURB-65 in Predicting 30-day mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30473.
    >> Share

  753. ALI S, Pappachan JM, Mathew S
    Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30474.
    >> Share

  754. LIU Z, Chu R, Gong L, Su B, et al
    The assessment of transmission efficiency and latent infection period on asymptomatic carriers of SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30471.
    >> Share

  755. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30466.
    >> Share

  756. RUTAYISIRE E, Nkundimana G, Mitonga HK, Boye A, et al
    What works and what does not work in response to COVID-19 prevention and control in Africa.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30460.
    >> Share

  757. PENARRUBIA AL, Ruiz M, Porco R, Rao SN, et al
    Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30463.
    >> Share

  758. LI Y, Wang H, Wang F, Du H, et al
    Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30462.
    >> Share

  759. XIAO Y, Tang B, Wu J, Cheke RA, et al
    Linking key intervention timings to rapid decline of the COVID-19 effective reproductive number to quantify lessons from mainland China.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30449.
    >> Share

  760. SZMUDA T, Ali S, Hetzger TV, Rosvall P, et al
    Are Online Searches for the Novel Coronavirus (COVID-19) Related to Media or Epidemiology? A Cross-sectional Study.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30464.
    >> Share

  761. MIYAMAE Y, Hayashi T, Yonezawa H, Fujihara J, et al
    Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30456.
    >> Share

  762. KILIC O, Kalcioglu MT, Cag Y, Tuysuz O, et al
    Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30458.
    >> Share

  763. BOHNING D, Rocchetti I, Maruotti A, Holling H, et al
    Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30444.
    >> Share

  764. ZHOU Y, Zeng Y, Chen C
    Presence of SARS-CoV-2 RNA in Isolation Ward Environment 28 Days after Exposure.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30451.
    >> Share

  765. SANTOS JAD, Normando AGC, Silva RLCD, Paula RM, et al
    Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
    Int J Infect Dis. 2020 Jun 8. pii: S1201-9712(20)30447.
    >> Share

  766. FINZI E
    Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30441.
    >> Share

  767. AZIZ H, Fatima S, Iqbal H, Faheem M, et al
    Recent Advances in Molecular diagnosis curbing the COVID-19.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30439.
    >> Share

  768. ESPINDOLA OM, Siqueira M, Soares CN, Lima MASD, et al
    Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
    Int J Infect Dis. 2020 Jun 4. pii: S1201-9712(20)30431.
    >> Share

  769. LI H, Xu XL, Dai DW, Huang ZY, et al
    Air Pollution and temperature are associated with increased COVID-19 incidence: a time series study.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30383.
    >> Share

  770. ZHANG L, Tao Y, Wang J, Ong JJ, et al
    Early characteristics of the COVID-19 outbreak predict the subsequent epidemic size.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30429.
    >> Share

  771. LEE KCH, Sewa DW, Phua GC
    Potential role of statins in COVID-19.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30422.
    >> Share

  772. MIZUMOTO K, Kagaya K, Chowell G
    Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30398.
    >> Share

  773. EDEAS M, Saleh J, Peyssonnaux C
    Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30417.
    >> Share

  774. MACINTYRE CR, Chughtai AA, Seale H, Dwyer DE, et al
    HUMAN CORONAVIRUS DATA FROM FOUR CLINICAL TRIALS OF MASKS AND RESPIRATORS.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30399.
    >> Share

  775. PORTE L, Legarraga P, Vollrath V, Aguilera X, et al
    Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30405.
    >> Share

  776. SHAH AUM, Safri SNA, Thevadas R, Noordin NK, et al
    COVID-19 Outbreak in Malaysia: Actions Taken by the Malaysian Government.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30400.
    >> Share

  777. MING DK, Sorawat S, Chanh HQ, Nhat PTH, et al
    Continuous physiological monitoring using wearable technology to inform individual management of infectious diseases, public health and outbreak responses.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30393.
    >> Share

  778. KENYON C
    The prominence of asymptomatic superspreaders in transmission mean universal face masking should be part of COVID-19 de-escalation strategies.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30409.
    >> Share

  779. LUO S, Guo Y, Zhang X, Xu H, et al
    A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30426.
    >> Share

  780. PAPAMICHALIS P, Papadogoulas A, Katsiafylloudis P, Skoura AL, et al
    Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30425.
    >> Share

  781. BUONSENSO D, Cinicola B, Raffaelli F, Sollena P, et al
    Social consequences of COVID-19 in a low resource setting in Sierra Leone, West Africa.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30411.
    >> Share

  782. RUOCCO G, Feola M, Palazzuoli A
    Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.
    Int J Infect Dis. 2020;95:373-375.
    >> Share

  783. WU D, Lu J, Liu Y, Zhang Z, et al
    Positive effects of COVID-19 control measures on influenza prevention.
    Int J Infect Dis. 2020;95:345-346.
    >> Share

    May 2020
  784. LI P, Chen L, Liu Z, Pan J, et al
    Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30415.
    >> Share

  785. ITAYA T, Furuse Y, Jindai K
    Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30395.
    >> Share

  786. ALCOBA-FLOREZ J, Gonzalez-Montelongo R, Inigo-Campos A, de Artola DG, et al
    Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30406.
    >> Share

  787. KANG CK, Han GC, Kim M, Kim G, et al
    Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30413.
    >> Share

  788. DE MEYER S, Bojkova D, Cinatl J, Van Damme E, et al
    Lack of Antiviral Activity of Darunavir against SARS-CoV-2.
    Int J Infect Dis. 2020 May 29. pii: S1201-9712(20)30392.
    >> Share

  789. MA S, Lai X, Chen Z, Tu S, et al
    Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30375.
    >> Share

  790. MIDDELBURG RA, Rosendaal FR
    COVID-19: how to make between-country comparisons.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30373.
    >> Share

  791. LIN YC, Cheng CY, Cheng-Pin C, Cheng SH, et al
    A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30377.
    >> Share

  792. RIVAS AL, Febles JL, Smith SD, Hoogesteijn AL, et al
    Early network properties of the COVID-19 pandemic - the Chinese scenario.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30356.
    >> Share

  793. JANG S, Rhee JY
    Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30379.
    >> Share

  794. WANG Q, Hu Z
    Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30372.
    >> Share

  795. WU D, Lu J, Cao L, Ma X, et al
    Positive effects of COVID-19 control measures on pneumonia prevention.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30376.
    >> Share

  796. OLUM R, Bongomin F
    Uganda's First 100 COVID-19 Cases: Trends and Lessons.
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30380.
    >> Share

  797. EAASWARKHANTH M, Madhoun AA, Al-Mulla F
    Could the D614 G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30378.
    >> Share

  798. ANDREA V, Gianluca F, Rodolfo P, Paolo T, et al
    Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.
    Int J Infect Dis. 2020 May 21. pii: S1201-9712(20)30367.
    >> Share

  799. BEARMAN G, Pryor R, Vokes R, Cooper K, et al
    Reflections on the COVID-19 Pandemic in the USA: Will We Better Prepared Next Time?
    Int J Infect Dis. 2020 May 20. pii: S1201-9712(20)30366.
    >> Share

  800. ZENG F, Huang Y, Guo Y, Yin M, et al
    Association of inflammatory markers with the severity of COVID-19: a meta-analysis.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30362.
    >> Share

  801. MARAIS BJ, Sorrell TC
    Pathways to COVID-19 'community protection'.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30365.
    >> Share

  802. OVERHOFF D, Walter T, Gruettner J, Janssen S, et al
    Acute pulmonary embolism mimicking COVID - 19 pneumonia.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30360.
    >> Share

  803. ZUMLA A, Wang FS, Ippolito G, Petrosillo N, et al
    Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30347.
    >> Share

  804. MACHIDA M, Nakamura I, Saito R, Nakaya T, et al
    Changes in implementation of personal protective measures by ordinary Japanese citizens: A longitudinal study from the early phase to the community transmission phase of the COVID-19 outbreak.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30346.
    >> Share

  805. QI L, Yang Y, Jiang D, Tu C, et al
    Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30352.
    >> Share

  806. HOEFER A, Pampaka D, Wagner ER, Herrera AA, et al
    Management of a COVID-19 outbreak in a Hotel in Tenerife, Spain.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30354.
    >> Share

  807. XIA Y, Hong H, Feng Y, Liu M, et al
    Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30349.
    >> Share

  808. ZHAO N, Liu Y, Smaragiassi A, Bernatsky S, et al
    Tracking the origin of early COVID-19 cases in Canada.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30353.
    >> Share

  809. HU B, Qiu J, Chen H, Tao V, et al
    First, second and potential third generation spreads of the COVID-19 epidemic in mainland China: an early exploratory study incorporating location-based service data of mobile devices.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30355.
    >> Share

  810. RAINISCH G, Undurraga EA, Chowell G
    A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions.
    Int J Infect Dis. 2020 May 16. pii: S1201-9712(20)30350.
    >> Share

  811. FRANZETTI M, Pozzetti U, Carugati M, Pandolfo A, et al
    Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 May 15. pii: S1201-9712(20)30357.
    >> Share

  812. CHONG KC, Cheng W, Zhao S, Ling F, et al
    Monitoring disease transmissibility of 2019 novel coronavirus disease in Zhejiang, China.
    Int J Infect Dis. 2020;96:128-130.
    >> Share

  813. CALDERARO A, Arcangeletti MC, De Conto F, Buttrini M, et al
    SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30342.
    >> Share

  814. LEE H, Park SJ, Lee GR, Kim JE, et al
    The Relationship between the COVID-19 Prevalence Trend and Transportation Trend in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30339.
    >> Share

  815. KIM S, Jeong YD, Byun JH, Cho G, et al
    Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30343.
    >> Share

  816. WORKMAN J
    Proportion of COVID-19 Cases that Are Asymptomatic in South Korea: Comment on Nishiura et al.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30344.
    >> Share

  817. KOWALSKA JD, Skrzat-Klapaczynska A, Bursa D, Balayan T, et al
    HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe?
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30319.
    >> Share

  818. MBOERA LEG, Akipede GO, Banerjee A, Cuevas LE, et al
    Mitigating lockdown challenges in the response to COVID-19 in Sub-Saharan Africa.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30325.
    >> Share

  819. FAN H, Zhang L, Huang B, Zhu M, et al
    Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30331.
    >> Share

  820. FILOCAMO G, Mangioni D, Tagliabue P, Aliberti S, et al
    Use of anakinra in severe COVID-19: a case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30333.
    >> Share

  821. ZHOU R, Li F, Chen F, Liu H, et al
    Viral dynamics in asymptomatic patients with COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30337.
    >> Share

  822. GUALANO G, Musso M, Mosti S, Mencarini P, et al
    Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30334.
    >> Share

  823. SOARES F, Yamashita GH
    On the crucial role of multilingual biomedical databases on epidemic events (SARS-CoV-2 analysis).
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30330.
    >> Share

  824. CHINTALAPUDI N, Battineni G, Sagaro GG, Amenta F, et al
    COVID-19 outbreak reproduction number estimations and forecasting in Marche, Italy.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30336.
    >> Share

  825. BELDOMENICO PM
    Do superspreaders generate new superspreaders? a hypothesis to explain the propagation pattern of COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30332.
    >> Share

  826. RAN J, Zhao S, Zhuang Z, Chong MK, et al
    Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of outbreak in Hong Kong in 2020.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30321.
    >> Share

  827. BORGHESI A, Zigliani A, Golemi S, Carapella N, et al
    Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30328.
    >> Share

  828. PUTRA BE, Adiarto S, Dewayanti SR, Juzar DA, et al
    Viral Exanthem with "Pin and Needles Sensation" on Extremities of COVID-19 Patient.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30327.
    >> Share

  829. SO MKP, Tiwari A, Chu AMY, Tsang JTY, et al
    Visualising COVID-19 Pandemic Risk through Network Connectedness.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30317.
    >> Share

  830. SHANG Y, Xu C, Jiang F, Huang R, et al
    Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China.
    Int J Infect Dis. 2020;96:157-162.
    >> Share

  831. SHEN M, Peng Z, Guo Y, Rong L, et al
    Assessing the Effects of Metropolitan-Wide Quarantine on the Spread of COVID-19 in Public Space and Households.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30326.
    >> Share

  832. ABBARA A, Rayes D, Fahham O, Alhiraki OA, et al
    Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria.
    Int J Infect Dis. 2020;96:192-195.
    >> Share

  833. GALLINA P, Ricci M
    Covid-19 health crisis management in Europe: decisive assessment is needed now.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30316.